| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.83e-06 | 85 | 304 | 9 | GO:0019199 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.26e-06 | 65 | 304 | 8 | GO:0004714 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 ERBB3 ERBB4 CRIM1 AXL SPEG PAK4 OBSCN SCYL1 PFKFB2 AK7 FN3K TYRO3 BMPR1B AK5 MYO3B TAOK1 AKT1 FGFR2 PLK1 SGIP1 TENT4A POLRMT ERN2 LIMK1 AATK GYS1 MAST1 CARD11 SRPK3 ROS1 | 4.49e-05 | 938 | 304 | 31 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 ERBB3 ERBB4 CRIM1 AXL SPEG PAK4 OBSCN SCYL1 PFKFB2 AK7 FN3K TYRO3 BMPR1B AK5 MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 CARD11 SRPK3 ROS1 | 4.64e-05 | 764 | 304 | 27 | GO:0016301 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.65e-05 | 46 | 304 | 6 | GO:0005245 | |
| GeneOntologyMolecularFunction | neuregulin binding | 6.75e-05 | 6 | 304 | 3 | GO:0038132 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.78e-05 | 145 | 304 | 10 | GO:0004713 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 ERBB3 ERBB4 CRIM1 AXL SPEG PAK4 OBSCN SCYL1 TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 1.41e-04 | 600 | 304 | 22 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 ERBB3 ERBB4 CRIM1 AXL SPEG PAK4 OBSCN SCYL1 PFKFB2 FN3K TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 2.35e-04 | 709 | 304 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | collagen binding | 2.35e-04 | 81 | 304 | 7 | GO:0005518 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.74e-04 | 9 | 304 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.74e-04 | 9 | 304 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYO9B IQSEC2 RGPD1 OBSCN GBP3 ARHGEF17 DENND2B PLEKHG1 RGPD5 RGPD8 RASA1 DOCK8 OCRL ARHGAP35 RGS3 TBC1D8 ARHGDIA ARHGDIG ARAP3 | 3.06e-04 | 507 | 304 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYO9B IQSEC2 RGPD1 OBSCN GBP3 ARHGEF17 DENND2B PLEKHG1 RGPD5 RGPD8 RASA1 DOCK8 OCRL ARHGAP35 RGS3 TBC1D8 ARHGDIA ARHGDIG ARAP3 | 3.06e-04 | 507 | 304 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | Rho GDP-dissociation inhibitor activity | 6.86e-04 | 3 | 304 | 2 | GO:0005094 | |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 6.86e-04 | 3 | 304 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.58e-04 | 73 | 304 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPP1 PAK4 OBSCN SCYL1 ITGA5 ITGA7 ITGB4 NLGN3 PTPRO CNTN1 COL3A1 NPHS1 VTN FN1 DSC2 KLC2 ARVCF TNKS1BP1 TNXB CDH13 | 9.15e-04 | 599 | 304 | 20 | GO:0050839 |
| GeneOntologyMolecularFunction | enzyme regulator activity | ERBB3 CRIM1 PDGFB MYO9B IQSEC2 RGPD1 OBSCN GBP3 ARHGEF17 BIRC6 DENND2B ZEB2 ITIH4 PLEKHG1 MYOZ1 TAOK1 AKT1 MMP16 RGPD5 FN1 RGPD8 RASA1 PI16 DOCK8 PPP6R1 OCRL ARHGAP35 RGS3 RBCK1 TBC1D8 WDR91 ARHGDIA ARHGDIG ARAP3 IRS2 NRG3 ATP2A3 | 9.42e-04 | 1418 | 304 | 37 | GO:0030234 |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 ERBB4 ERCC2 PDGFB SPEG GATA3 ITGA5 PCDH12 BIRC6 SCX ZEB2 AXIN2 BAP1 HDAC3 MYO3B CC2D2A DLD RRP7A AKT1 FGFR2 MMP16 COL3A1 FRAS1 ZEB1 VTN SLC4A8 FN1 PRAMEF22 APBA2 EPB41L5 SMPD4 G2E3 OCRL ARHGAP35 PAF1 ARHGDIG GTF2I ZNF335 FRZB UBR3 CNOT1 PCDH8 TP53BP2 | 4.00e-06 | 1437 | 297 | 43 | GO:0009790 |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB2 MAG ERBB4 ERCC2 AXL SCYL1 RTN1 ZEB2 AK7 FANCD2 TYRO3 NLGN3 BMPR1B SYNE2 TAOK1 AKT1 FGFR2 AGTPBP1 CNTN1 COL3A1 CACNA1A FAT4 XRN2 ZEB1 VTN POMGNT1 ARHGAP35 WDR47 AATK CELSR2 ASCL1 ZNF335 MAST1 ZNF76 KDM4A IRS2 NRG3 TP53BP2 | 4.04e-06 | 1197 | 297 | 38 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose import | 7.03e-06 | 50 | 297 | 7 | GO:0046326 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB2 ERBB3 ERBB4 ERCC2 HTRA1 CRIM1 PDGFB AXL GATA3 ITGA5 SMOC2 GDF9 SCX ZEB2 RYR1 TYRO3 BMPR1B PTPRK AKT1 FGFR2 PHIP BRMS1 COL3A1 FAT4 SOST ZEB1 VTN SFRP4 RASA1 RELA CSPG4 APPL1 ROS1 IRS2 NRG3 TNXB CDH13 | 8.11e-06 | 1186 | 297 | 37 | GO:0007167 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ERCC2 PDGFB SPEG GATA3 PCDH12 BIRC6 SCX ZEB2 AXIN2 BAP1 HDAC3 CC2D2A RRP7A AKT1 FGFR2 MMP16 COL3A1 ZEB1 PRAMEF22 APBA2 EPB41L5 SMPD4 G2E3 OCRL ARHGAP35 ARHGDIG ZNF335 UBR3 CNOT1 PCDH8 TP53BP2 | 1.28e-05 | 929 | 297 | 31 | GO:0009792 |
| GeneOntologyBiologicalProcess | gliogenesis | MAG ERBB3 ERCC2 PDGFB ITGB4 ZEB2 ADCYAP1 NLGN3 SYNE2 AKT1 CNTN1 COL3A1 VTN FN1 RELA WDR47 ASCL1 CSPG4 KDM4A | 1.98e-05 | 435 | 297 | 19 | GO:0042063 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ERCC2 PDGFB SPEG GATA3 PCDH12 BIRC6 SCX ZEB2 AXIN2 BAP1 HDAC3 CC2D2A RRP7A AKT1 FGFR2 MMP16 COL3A1 ZEB1 PRAMEF22 APBA2 EPB41L5 SMPD4 G2E3 OCRL ARHGAP35 ARHGDIG ZNF335 UBR3 CNOT1 PCDH8 | 2.06e-05 | 906 | 297 | 30 | GO:0043009 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | PDGFB SPP1 AXL ITGA5 SMOC2 ITGA7 ITGB4 TYRO3 PTPRK PTPRO MMP12 COL3A1 VTN FN1 RASA1 EPB41L5 TNXB CDH13 | 3.06e-05 | 410 | 297 | 18 | GO:0031589 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 ERBB4 PDGFB IQSEC2 ZMYND8 MPDZ ITGA5 ITGB4 NLGN3 PTPN13 HMCN2 PTPRK PTPRO AKT1 FGFR2 MAPRE2 CAP2 UNC13B NPHS1 CACNA1A SORBS2 FN1 EPB41L5 SHANK2 SLC18A3 VPS35 APPL1 NRG3 OCLN PCDH8 CDH13 | 3.18e-05 | 974 | 297 | 31 | GO:0034330 |
| GeneOntologyBiologicalProcess | response to growth factor | ERBB4 HTRA1 CRIM1 PDGFB GATA3 ITGA5 SMOC2 GDF9 SCX ZEB2 RYR1 BMPR1B PTPRK AKT1 FGFR2 ALPG BRMS1 COL3A1 FAT4 SOST ZEB1 VTN SFRP4 RASA1 EPB41L5 RELA ASCL1 APPL1 TNXB | 3.31e-05 | 883 | 297 | 29 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 3.32e-05 | 63 | 297 | 7 | GO:0010828 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG CD300A PAK4 GATA3 ITGA5 PCDH12 ITGA7 ITGB4 TYRO3 NLGN3 HMCN2 PDIA2 ASTN2 AKT1 CNTN1 NPHS1 FAT4 DSC2 PCDHGB3 DOCK8 FAT3 EPB41L5 PCDHAC1 RELA ARG2 CELSR2 ARVCF SMARCC2 CARD11 PCDH1 TNXB PCDH8 CDH13 | 3.71e-05 | 1077 | 297 | 33 | GO:0098609 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ERBB4 HTRA1 CRIM1 PDGFB GATA3 ITGA5 SMOC2 GDF9 SCX ZEB2 RYR1 BMPR1B PTPRK AKT1 FGFR2 ALPG BRMS1 COL3A1 FAT4 SOST ZEB1 VTN SFRP4 RASA1 EPB41L5 RELA APPL1 TNXB | 4.31e-05 | 850 | 297 | 28 | GO:0071363 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB2 MAG ERCC2 PAK4 OBSCN GATA3 ITGA5 SMOC2 ITGB4 SCX ZEB2 AXIN2 MYOZ1 NFKB2 CC2D2A RRP7A AKT1 CACNA1H FGFR2 AGTPBP1 CNTN1 COL3A1 NPHS1 CACNA1A FLNC VTN FN1 NEBL PRAMEF22 FAT3 EPB41L5 RELA SH2D2A ARHGAP35 PAF1 GTF2I CSPG4 NRG3 CNOT1 PCDH8 CDH13 | 4.35e-05 | 1483 | 297 | 41 | GO:0048646 |
| GeneOntologyBiologicalProcess | in utero embryonic development | ERCC2 PDGFB SPEG GATA3 PCDH12 BIRC6 BAP1 HDAC3 RRP7A AKT1 FGFR2 COL3A1 PRAMEF22 APBA2 EPB41L5 SMPD4 G2E3 OCRL ARHGDIG ZNF335 UBR3 CNOT1 | 5.74e-05 | 596 | 297 | 22 | GO:0001701 |
| GeneOntologyBiologicalProcess | response to interleukin-18 | 6.69e-05 | 16 | 297 | 4 | GO:0070673 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ITGA5 ZEB2 ADCYAP1 AXIN2 TYRO3 HDAC3 AKT1 FGFR2 PLK1 PHIP CNTN1 VTN RGPD8 RASA1 ERN2 CSPG4 SPDYE3 TNKS1BP1 ROS1 HCLS1 | 6.73e-05 | 780 | 297 | 26 | GO:0042327 |
| GeneOntologyBiologicalProcess | developmental maturation | ATP6V1A ERBB4 ERCC2 ATP6V0A1 CATSPERE PDGFB ADAM7 GATA3 RYR1 BAP1 DLD AKT1 CACNA1A FAT4 ASCL1 CSPG4 VPS35 CATSPERB | 7.39e-05 | 439 | 297 | 18 | GO:0021700 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | EPHB2 SCYL1 ZEB2 BMPR1B TAOK1 FGFR2 AGTPBP1 CACNA1A ARHGAP35 WDR47 ASCL1 ZNF335 | 7.72e-05 | 217 | 297 | 12 | GO:0021953 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB2 ERBB3 ERBB4 ERCC2 CRIM1 PDGFB AXL GATA3 ITGA5 SMOC2 TYRO3 AKT1 FGFR2 PHIP FAT4 VTN RASA1 RELA CSPG4 APPL1 ROS1 IRS2 NRG3 TNXB CDH13 | 8.74e-05 | 747 | 297 | 25 | GO:0007169 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDH12 HMCN2 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 8.85e-05 | 187 | 297 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | EPHB2 ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ITGA5 ZEB2 ADCYAP1 AXIN2 TYRO3 HDAC3 LIME1 PTPN13 PTPRO AKT1 FGFR2 PLK1 PHIP CNTN1 VTN FN1 RGPD8 RASA1 ERN2 MIDN CSPG4 SPDYE3 TNKS1BP1 ROS1 IRS2 OCLN TNXB HCLS1 | 8.88e-05 | 1226 | 297 | 35 | GO:0042325 |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 9.26e-05 | 99 | 297 | 8 | GO:0021954 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EPHB2 PDGFB ZMYND8 ZNF207 ZEB2 AXIN2 MYO3B SYNE2 WDR35 TAOK1 AKT1 FGFR2 SHCBP1L PLK1 MAPRE2 PHIP RAD21 NPHS1 RASA1 EML4 SMC6 DZIP1 ARHGAP35 WDR47 TBC1D8 LIMK1 ABCG1 L3MBTL1 VPS35 YLPM1 SENP6 SMARCC2 RIMBP2 OCLN BUB3 CNOT1 HCLS1 | 1.12e-04 | 1342 | 297 | 37 | GO:0033043 |
| GeneOntologyBiologicalProcess | brain development | EPHB2 ERBB4 AXL RTN1 ZEB2 AK7 FANCD2 TYRO3 SYNE2 FGFR2 AGTPBP1 CNTN1 COL3A1 CACNA1A FAT4 XRN2 ZEB1 POMGNT1 ARHGAP35 WDR47 AATK CELSR2 ASCL1 ZNF335 MAST1 IRS2 NRG3 | 1.29e-04 | 859 | 297 | 27 | GO:0007420 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPHB2 PDGFB ZMYND8 ITGB4 AK7 IFT43 NME8 PTPRO MYO3B SYNE2 WDR35 CC2D2A AKT1 IQUB SPATA6 OCRL DZIP1 ARHGAP35 TBC1D8 CELSR2 CSPG4 OCLN CDH13 | 1.60e-04 | 685 | 297 | 23 | GO:0030031 |
| GeneOntologyBiologicalProcess | head development | EPHB2 ERBB4 AXL SCX RTN1 ZEB2 AK7 FANCD2 TYRO3 SYNE2 FGFR2 AGTPBP1 CNTN1 COL3A1 CACNA1A FAT4 XRN2 ZEB1 POMGNT1 ARHGAP35 WDR47 AATK CELSR2 ASCL1 ZNF335 MAST1 IRS2 NRG3 | 1.63e-04 | 919 | 297 | 28 | GO:0060322 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | EPHB2 ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ZEB2 ADCYAP1 AXIN2 TYRO3 LIME1 PTPRO AKT1 FGFR2 PLK1 RGPD8 ERN2 MIDN SPDYE3 ROS1 IRS2 TNXB | 1.64e-04 | 686 | 297 | 23 | GO:0043549 |
| GeneOntologyBiologicalProcess | regulation of D-glucose import | 1.67e-04 | 81 | 297 | 7 | GO:0046324 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG ITGA5 PCDH12 HMCN2 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 ARVCF PCDH1 PCDH8 CDH13 | 1.92e-04 | 313 | 297 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | slit diaphragm assembly | 2.07e-04 | 2 | 297 | 2 | GO:0036060 | |
| GeneOntologyBiologicalProcess | neuron cellular homeostasis | 2.10e-04 | 84 | 297 | 7 | GO:0070050 | |
| GeneOntologyBiologicalProcess | central nervous system myelin formation | 2.33e-04 | 9 | 297 | 3 | GO:0032289 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 ERBB4 PDGFB IQSEC2 MPDZ ITGA5 ITGB4 NLGN3 PTPN13 PTPRK PTPRO NPHS1 CACNA1A FN1 EPB41L5 SHANK2 VPS35 NRG3 OCLN CDH13 | 2.38e-04 | 569 | 297 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 MAG SPP1 MYO9B ADAM7 GATA3 ITGA7 ZEB2 BRWD3 BAP1 NLGN3 BMPR1B HMCN2 PTPRO MYO3B FGFR2 PHIP CAP2 CNTN1 CACNA1A FN1 RASA1 FAT3 EPB41L5 ARHGAP35 IDUA WDR47 ARHGDIA LIMK1 CELSR2 ZNF335 ZMYM3 CDH13 | 2.58e-04 | 1194 | 297 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | forebrain development | EPHB2 ERBB4 AXL ZEB2 TYRO3 SYNE2 FGFR2 AGTPBP1 COL3A1 FAT4 XRN2 ZEB1 POMGNT1 ARHGAP35 WDR47 ASCL1 ZNF335 NRG3 | 2.80e-04 | 489 | 297 | 18 | GO:0030900 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ZEB2 ADCYAP1 AXIN2 TYRO3 AKT1 FGFR2 RGPD8 ERN2 SPDYE3 ROS1 | 2.80e-04 | 405 | 297 | 16 | GO:0033674 |
| GeneOntologyBiologicalProcess | neuron development | MYT1L EPHB2 MAG PDGFB SPP1 PAK4 ZMYND8 GATA3 SCYL1 MPDZ PCDH12 ZEB2 ADCYAP1 NLGN3 BMPR1B HMCN2 PTPRK PTPRO MYO3B TAOK1 AKT1 FGFR2 AGTPBP1 CNTN1 CACNA1A FAT4 FN1 FAT3 PCARE ARHGAP35 WDR47 LIMK1 CELSR2 TMEM132E ASCL1 ZNF335 CSPG4 TNXB | 3.00e-04 | 1463 | 297 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPHB2 ZMYND8 ITGB4 AK7 IFT43 NME8 PTPRO MYO3B SYNE2 WDR35 CC2D2A AKT1 IQUB SPATA6 OCRL DZIP1 ARHGAP35 TBC1D8 CELSR2 CSPG4 OCLN CDH13 | 3.03e-04 | 670 | 297 | 22 | GO:0120031 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ERCC2 SMOC2 SCX AXIN2 NFKB2 MMP12 MMP16 COL3A1 VTN FN1 MMP23B POMGNT1 VWA1 IDUA TNXB | 4.02e-04 | 377 | 297 | 15 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ERCC2 SMOC2 SCX AXIN2 NFKB2 MMP12 MMP16 COL3A1 VTN FN1 MMP23B POMGNT1 VWA1 IDUA TNXB | 4.13e-04 | 378 | 297 | 15 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ERCC2 SMOC2 SCX AXIN2 NFKB2 MMP12 MMP16 COL3A1 VTN FN1 MMP23B POMGNT1 VWA1 IDUA TNXB | 4.24e-04 | 379 | 297 | 15 | GO:0045229 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB2 ERBB3 SPG7 PDGFB SPP1 CD300A GATA3 ITGA5 SMOC2 PTPRO AKT1 MMP12 APBB1IP VTN FN1 RASA1 DOCK8 EPB41L5 RELA ARG2 ARHGDIG CELSR2 SMARCC2 CARD11 TNXB PCDH8 CDH13 | 4.32e-04 | 927 | 297 | 27 | GO:0030155 |
| GeneOntologyBiologicalProcess | bone morphogenesis | 4.37e-04 | 124 | 297 | 8 | GO:0060349 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ITGA5 ZEB2 ADCYAP1 AXIN2 TYRO3 HDAC3 AKT1 FGFR2 PLK1 PHIP CNTN1 VTN RGPD8 RASA1 ERN2 CSPG4 SPDYE3 TNKS1BP1 ROS1 HCLS1 | 4.38e-04 | 879 | 297 | 26 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | ERBB3 ERBB4 PDGFB AXL CD300A RGPD1 ITGA5 ZEB2 ADCYAP1 AXIN2 TYRO3 HDAC3 AKT1 FGFR2 PLK1 PHIP CNTN1 VTN RGPD8 RASA1 ERN2 CSPG4 SPDYE3 TNKS1BP1 ROS1 HCLS1 | 4.38e-04 | 879 | 297 | 26 | GO:0045937 |
| GeneOntologyBiologicalProcess | glial cell development | 4.65e-04 | 157 | 297 | 9 | GO:0021782 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | ERBB4 PDGFB OBSCN TYRO3 MYO3B TAOK1 AKT1 FGFR2 AATK TNKS1BP1 ROS1 | 4.93e-04 | 228 | 297 | 11 | GO:0046777 |
| GeneOntologyBiologicalProcess | organelle assembly | EPHB2 OBSCN ZNF207 AK7 IFT43 NME8 HDAC3 NLGN3 MYOZ1 SYNE2 WDR35 CC2D2A RRP7A AKT1 PLK1 MAPRE2 IQUB KIF11 FLNC ATG9B SPATA6 NEBL NOA1 OCRL DZIP1 ARHGAP35 TBC1D8 CELSR2 KASH5 SENP6 CNOT1 | 5.09e-04 | 1138 | 297 | 31 | GO:0070925 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.72e-05 | 46 | 299 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 ERBB4 TSPOAP1 IQSEC2 MPDZ ITGA5 PDE10A ITGB4 NLGN3 KCND2 PTPRO AKT1 CACNA1H CNTN1 UNC13B PRUNE2 CACNA1A SLC4A8 RELA LIMK1 SHANK2 VPS35 APPL1 RIMBP2 GSG1L NRG3 PCDH8 | 5.04e-05 | 817 | 299 | 27 | GO:0098978 |
| GeneOntologyCellularComponent | basement membrane | 6.60e-05 | 122 | 299 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | cell leading edge | MYO9B ITGA5 ITGB4 PTPN13 PTPRK PTPRO SYNE2 AKT1 USH2A APBB1IP SORBS2 RASA1 DOCK8 EPB41L5 LIMK1 ARAP3 CSPG4 APPL1 OCLN | 1.17e-04 | 500 | 299 | 19 | GO:0031252 |
| GeneOntologyCellularComponent | anchoring junction | DCAF6 PAK4 OBSCN MPDZ ITGA5 PCDH12 ITGA7 ITGB4 PTPRK KCND2 SYNE2 AKT1 MAPRE2 APBB1IP NPHS1 FLNC SORBS2 DSC2 EPB41L5 LIMK1 ARVCF CSPG4 ANO7 TNKS1BP1 OCLN FYB1 PCDH1 CDH13 ATP6V0A2 | 1.70e-04 | 976 | 299 | 29 | GO:0070161 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HTRA1 PDGFB SMOC2 ITGB4 ITIH4 HMCN2 FGFR2 USH2A COL3A1 NPHS1 FRAS1 SOST VTN FN1 MMP23B VWA1 CSPG4 TNXB CDH13 | 2.45e-04 | 530 | 299 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | presynapse | EPHB2 ATP6V1A ERBB4 ATP6V0A1 TSPOAP1 IQSEC2 ADCYAP1 NLGN3 CLCN5 OTOF CACNA1H USH2A CNTN1 UNC13B PRUNE2 CACNA1A SGIP1 SLC4A8 APBA2 SHANK2 SLC18A3 VPS35 SENP6 APPL1 RIMBP2 PCDH8 | 4.48e-04 | 886 | 299 | 26 | GO:0098793 |
| GeneOntologyCellularComponent | lamellipodium | MYO9B PTPN13 PTPRO SYNE2 AKT1 APBB1IP SORBS2 DOCK8 LIMK1 ARAP3 CSPG4 | 5.02e-04 | 230 | 299 | 11 | GO:0030027 |
| GeneOntologyCellularComponent | extracellular matrix | HTRA1 PDGFB SMOC2 ITGB4 ITIH4 HMCN2 FGFR2 MMP12 MMP16 USH2A COL3A1 NPHS1 FRAS1 SOST VTN FN1 MMP23B VWA1 CSPG4 TNXB CDH13 | 5.30e-04 | 656 | 299 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HTRA1 PDGFB SMOC2 ITGB4 ITIH4 HMCN2 FGFR2 MMP12 MMP16 USH2A COL3A1 NPHS1 FRAS1 SOST VTN FN1 MMP23B VWA1 CSPG4 TNXB CDH13 | 5.51e-04 | 658 | 299 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | alphav-beta3 integrin-vitronectin complex | 6.06e-04 | 3 | 299 | 2 | GO:0071062 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.21e-04 | 73 | 299 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | cell-substrate junction | DCAF6 PAK4 ITGA5 ITGA7 ITGB4 SYNE2 MAPRE2 APBB1IP NPHS1 FLNC SORBS2 EPB41L5 LIMK1 CSPG4 CDH13 ATP6V0A2 | 6.93e-04 | 443 | 299 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | postsynaptic membrane | EPHB2 ERBB3 ERBB4 IQSEC2 ITGA5 ITGB4 NLGN3 KCND2 PTPRO CACNA1H CNTN1 CACNA1A SHANK2 GSG1L PCDH8 | 7.85e-04 | 405 | 299 | 15 | GO:0045211 |
| GeneOntologyCellularComponent | cell body | EPHB2 ERBB4 PDGFB PDE10A RTN1 ADCYAP1 NLGN3 BMPR1B PTPN13 HMCN2 PTPRK KCND2 ASTN2 CACNA1H USH2A CACNA1A PITPNM2 SORBS2 SLC4A8 WDR47 SHANK2 TMEM132E LNPEP ASCL1 VPS35 MAST1 | 8.98e-04 | 929 | 299 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | focal adhesion | DCAF6 PAK4 ITGA5 ITGB4 SYNE2 MAPRE2 APBB1IP NPHS1 FLNC SORBS2 EPB41L5 LIMK1 CSPG4 CDH13 ATP6V0A2 | 1.46e-03 | 431 | 299 | 15 | GO:0005925 |
| GeneOntologyCellularComponent | Z disc | 1.52e-03 | 151 | 299 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.54e-03 | 59 | 299 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | postsynapse | EPHB2 ERBB3 ERBB4 MYO9B IQSEC2 ZMYND8 RUSC1 MPDZ ITGA5 ITGB4 RTN1 NLGN3 KCND2 PTPRO AKT1 CACNA1H CAP2 CNTN1 CACNA1A APBA2 LIMK1 SHANK2 VPS35 SENP6 APPL1 GSG1L PCDH8 | 1.57e-03 | 1018 | 299 | 27 | GO:0098794 |
| Domain | FN3 | EPHB2 TSPOAP1 AXL SPEG OBSCN ITGB4 TYRO3 PTPRK PTPRO ASTN2 USH2A CNTN1 NPHS1 FLNC FN1 TRIM42 VWA1 RIMBP2 ROS1 TNXB | 1.77e-11 | 185 | 298 | 20 | SM00060 |
| Domain | fn3 | EPHB2 TSPOAP1 AXL SPEG OBSCN ITGB4 TYRO3 PTPRK PTPRO USH2A CNTN1 NPHS1 FN1 TRIM42 VWA1 RIMBP2 ROS1 TNXB | 1.18e-10 | 162 | 298 | 18 | PF00041 |
| Domain | FN3_dom | EPHB2 TSPOAP1 AXL SPEG OBSCN ITGB4 TYRO3 PTPRK PTPRO ASTN2 USH2A CNTN1 NPHS1 FLNC FN1 TRIM42 VWA1 RIMBP2 ROS1 TNXB | 1.64e-10 | 209 | 298 | 20 | IPR003961 |
| Domain | FN3 | EPHB2 TSPOAP1 AXL SPEG OBSCN ITGB4 TYRO3 PTPRK PTPRO ASTN2 USH2A CNTN1 NPHS1 FN1 TRIM42 VWA1 RIMBP2 ROS1 TNXB | 4.93e-10 | 199 | 298 | 19 | PS50853 |
| Domain | Kinase-like_dom | EPHB2 ERBB3 ERBB4 AXL SPEG PAK4 OBSCN SCYL1 FN3K TYRO3 BMPR1B PTPN13 MYO3B TAOK1 AKT1 FGFR2 PLK1 ARHGAP35 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 7.04e-06 | 542 | 298 | 24 | IPR011009 |
| Domain | Ig-like_fold | EPHB2 MAG TSPOAP1 AXL SPEG CD300A OBSCN ITGB4 TYRO3 HMCN2 PTPRK PTPRO NFKB2 ASTN2 FGFR2 USH2A CNTN1 NPHS1 FLNC FN1 TRIM42 MMP23B RELA VWA1 SHANK2 RIMBP2 ROS1 TNXB | 9.56e-06 | 706 | 298 | 28 | IPR013783 |
| Domain | Cadherin_CS | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 9.74e-06 | 109 | 298 | 10 | IPR020894 |
| Domain | CADHERIN_1 | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.34e-05 | 113 | 298 | 10 | PS00232 |
| Domain | Cadherin | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.34e-05 | 113 | 298 | 10 | PF00028 |
| Domain | - | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.45e-05 | 114 | 298 | 10 | 2.60.40.60 |
| Domain | CADHERIN_2 | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.45e-05 | 114 | 298 | 10 | PS50268 |
| Domain | CA | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.57e-05 | 115 | 298 | 10 | SM00112 |
| Domain | Cadherin-like | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.69e-05 | 116 | 298 | 10 | IPR015919 |
| Domain | Cadherin | PCDH12 FAT4 DSC2 PCDHGB3 FAT3 PCDHAC1 CELSR2 PCDH1 PCDH8 CDH13 | 1.96e-05 | 118 | 298 | 10 | IPR002126 |
| Domain | - | EPHB2 MAG TSPOAP1 AXL SPEG CD300A OBSCN ITGB4 TYRO3 PTPRK PTPRO NFKB2 ASTN2 FGFR2 USH2A CNTN1 NPHS1 FLNC FN1 TRIM42 MMP23B RELA VWA1 RIMBP2 ROS1 TNXB | 2.44e-05 | 663 | 298 | 26 | 2.60.40.10 |
| Domain | PROTEIN_KINASE_TYR | 2.49e-05 | 97 | 298 | 9 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.49e-05 | 97 | 298 | 9 | IPR008266 | |
| Domain | Prot_kinase_dom | EPHB2 ERBB3 ERBB4 AXL SPEG PAK4 OBSCN SCYL1 TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 4.17e-05 | 489 | 298 | 21 | IPR000719 |
| Domain | Pkinase_Tyr | 4.25e-05 | 129 | 298 | 10 | PF07714 | |
| Domain | PROTEIN_KINASE_DOM | EPHB2 ERBB3 ERBB4 AXL SPEG PAK4 OBSCN SCYL1 TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 4.69e-05 | 493 | 298 | 21 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | EPHB2 ERBB3 ERBB4 AXL SPEG PAK4 OBSCN TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 ERN2 LIMK1 AATK MAST1 SRPK3 ROS1 | 5.20e-05 | 459 | 298 | 20 | PS00107 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 7.53e-05 | 138 | 298 | 10 | IPR001245 | |
| Domain | G_CP_dom | 1.34e-04 | 7 | 298 | 3 | IPR030378 | |
| Domain | G_CP | 1.34e-04 | 7 | 298 | 3 | PS51721 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 ERBB4 AXL SPEG PAK4 OBSCN TYRO3 BMPR1B MYO3B TAOK1 AKT1 FGFR2 PLK1 LIMK1 AATK SRPK3 ROS1 | 1.34e-04 | 379 | 298 | 17 | IPR017441 |
| Domain | PH_dom-like | IQSEC2 RGPD1 OBSCN ARHGEF17 LYST PLEKHG1 PTPN13 AKT1 APBB1IP RGPD5 RGPD8 RASA1 APBA2 EPB41L5 RGS3 ARAP3 APPL1 IRS2 | 1.80e-04 | 426 | 298 | 18 | IPR011993 |
| Domain | SH3 | TSPOAP1 OBSCN RUSC1 SORBS2 NEBL RASA1 SH3D21 SHANK2 RIMBP2 FYB1 HCLS1 TP53BP2 | 1.91e-04 | 216 | 298 | 12 | PS50002 |
| Domain | SH3 | TSPOAP1 OBSCN RUSC1 SORBS2 NEBL RASA1 SH3D21 SHANK2 RIMBP2 FYB1 HCLS1 TP53BP2 | 1.91e-04 | 216 | 298 | 12 | SM00326 |
| Domain | Growth_fac_rcpt_ | 2.08e-04 | 156 | 298 | 10 | IPR009030 | |
| Domain | SH3_domain | TSPOAP1 OBSCN RUSC1 SORBS2 NEBL RASA1 SH3D21 SHANK2 RIMBP2 FYB1 HCLS1 TP53BP2 | 2.26e-04 | 220 | 298 | 12 | IPR001452 |
| Domain | LAM_G_DOMAIN | 3.26e-04 | 38 | 298 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 4.16e-04 | 40 | 298 | 5 | PF02210 | |
| Domain | Tyr_kinase_cat_dom | 5.17e-04 | 88 | 298 | 7 | IPR020635 | |
| Domain | TyrKc | 5.17e-04 | 88 | 298 | 7 | SM00219 | |
| Domain | - | IQSEC2 RGPD1 OBSCN ARHGEF17 PLEKHG1 PTPN13 AKT1 APBB1IP RGPD8 RASA1 APBA2 EPB41L5 RGS3 ARAP3 APPL1 IRS2 | 5.79e-04 | 391 | 298 | 16 | 2.30.29.30 |
| Domain | GRIP | 6.03e-04 | 11 | 298 | 3 | PF01465 | |
| Domain | Grip | 6.03e-04 | 11 | 298 | 3 | SM00755 | |
| Domain | PDZ | 6.29e-04 | 148 | 298 | 9 | SM00228 | |
| Domain | LamG | 6.52e-04 | 44 | 298 | 5 | SM00282 | |
| Domain | - | 6.92e-04 | 150 | 298 | 9 | 2.30.42.10 | |
| Domain | PDZ | 7.26e-04 | 151 | 298 | 9 | PS50106 | |
| Domain | Period_circadian-like_C | 7.53e-04 | 3 | 298 | 2 | IPR022728 | |
| Domain | Period_C | 7.53e-04 | 3 | 298 | 2 | PF12114 | |
| Domain | - | 7.53e-04 | 3 | 298 | 2 | 2.70.50.30 | |
| Domain | Rho_GDI | 7.53e-04 | 3 | 298 | 2 | IPR000406 | |
| Domain | RhoGDI_domain | 7.53e-04 | 3 | 298 | 2 | IPR024792 | |
| Domain | Rho_GDI | 7.53e-04 | 3 | 298 | 2 | PF02115 | |
| Domain | PDZ | 7.61e-04 | 152 | 298 | 9 | IPR001478 | |
| Domain | Ubiquitin-rel_dom | MYO9B AXIN2 PTPN13 IQUB APBB1IP EPB41L5 RBCK1 MIDN ARAP3 TP53BP2 | 7.67e-04 | 184 | 298 | 10 | IPR029071 |
| Domain | Ran_BP1 | 7.95e-04 | 12 | 298 | 3 | PF00638 | |
| Domain | RANBD1 | 7.95e-04 | 12 | 298 | 3 | PS50196 | |
| Domain | GRIP | 7.95e-04 | 12 | 298 | 3 | PS50913 | |
| Domain | GRIP_dom | 7.95e-04 | 12 | 298 | 3 | IPR000237 | |
| Domain | - | WSB1 DCAF6 ARHGEF17 BIRC6 LYST BRWD3 WDR35 PHIP EML4 TAF1C WDR47 WDR91 DCAF11 BUB3 | 9.75e-04 | 333 | 298 | 14 | 2.130.10.10 |
| Domain | Ig_I-set | 9.81e-04 | 190 | 298 | 10 | IPR013098 | |
| Domain | I-set | 9.81e-04 | 190 | 298 | 10 | PF07679 | |
| Domain | WD40_repeat_dom | WSB1 DCAF6 ARHGEF17 LYST BRWD3 WDR35 PHIP EML4 TAF1C WDR47 WDR91 DCAF11 BUB3 | 1.02e-03 | 297 | 298 | 13 | IPR017986 |
| Domain | RanBD | 1.02e-03 | 13 | 298 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.02e-03 | 13 | 298 | 3 | IPR000156 | |
| Domain | WD40/YVTN_repeat-like_dom | WSB1 DCAF6 ARHGEF17 BIRC6 LYST BRWD3 WDR35 PHIP EML4 TAF1C WDR47 WDR91 DCAF11 BUB3 | 1.03e-03 | 335 | 298 | 14 | IPR015943 |
| Domain | V_ATPase_I | 1.49e-03 | 4 | 298 | 2 | PF01496 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.49e-03 | 4 | 298 | 2 | IPR016245 | |
| Domain | V-type_ATPase_116kDa_su_euka | 1.49e-03 | 4 | 298 | 2 | IPR026028 | |
| Domain | V-ATPase_116kDa_su | 1.49e-03 | 4 | 298 | 2 | IPR002490 | |
| Pathway | PID_RHOA_REG_PATHWAY | 9.00e-06 | 46 | 231 | 7 | M68 | |
| Pathway | KEGG_FOCAL_ADHESION | PDGFB SPP1 PAK4 ITGA5 ITGA7 ITGB4 AKT1 COL3A1 FLNC VTN FN1 ARHGAP35 TNXB | 2.46e-05 | 199 | 231 | 13 | M7253 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 2.99e-05 | 23 | 231 | 5 | M47537 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.88e-05 | 84 | 231 | 8 | M7098 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 9.92e-05 | 66 | 231 | 7 | M18 | |
| Pathway | WP_FOCAL_ADHESION | PDGFB SPP1 PAK4 ITGA5 ITGA7 ITGB4 AKT1 FLNC VTN FN1 ARHGAP35 TNXB | 1.09e-04 | 199 | 231 | 12 | M39402 |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.25e-04 | 48 | 231 | 6 | MM15479 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.53e-04 | 94 | 231 | 8 | MM15598 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4 | 1.79e-04 | 18 | 231 | 4 | M39327 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | ATP6V1A ERBB3 ERBB4 ATP6V0A1 PDGFB SPP1 AXL ADCYAP1 HDAC3 PTPRK PTPRO AKT1 FGFR2 COL3A1 FN1 RASA1 SH2D2A ASCL1 IRS2 NRG3 ATP6V0A2 | 1.81e-04 | 532 | 231 | 21 | M27870 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | MYO9B PAK4 PLEKHG1 DOCK8 LBR ARHGAP35 WDR91 ARHGDIA ARHGDIG ARAP3 | 2.37e-04 | 155 | 231 | 10 | M41808 |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 2.43e-04 | 54 | 231 | 6 | M29742 | |
| Pathway | WP_FOCAL_ADHESION | 2.62e-04 | 187 | 231 | 11 | MM15913 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 SPG7 MYO9B SPEG OBSCN PER1 ITGA5 BIRC6 LYST ITGB4 RYR1 BAP1 PLEKHG1 LIME1 PER2 NFKB2 RRP12 AKT1 CACNA1H FGFR2 UNC13B PITPNM2 FLNC FRAS1 SLC37A3 POLRMT TRMT1 POMGNT1 PPP6R1 ARHGAP35 IDUA AATK ARAP3 SHANK2 CELSR2 SLC12A4 ARVCF BTBD7 ZNF335 CSPG4 TNKS1BP1 IRS2 SPEN ATP2A3 CEP170B | 1.03e-17 | 1105 | 305 | 45 | 35748872 |
| Pubmed | LSG1 IQSEC2 RGPD1 MPDZ RTN1 ZEB2 ITIH4 HDAC3 NLGN3 SYNE2 CAP2 CNTN1 KIF11 CACNA1A DNAJC13 SORBS2 ZEB1 SGIP1 SLC4A8 RGPD8 PPP6R1 PAF1 WDR47 WDR91 SHANK2 CELSR2 ARVCF YLPM1 SMARCC2 APPL1 RIMBP2 BUB3 CNOT1 PCDH8 CEP170B TP53BP2 | 3.15e-13 | 963 | 305 | 36 | 28671696 | |
| Pubmed | TSPOAP1 SPEG ARHGEF17 ZEB2 USP19 PLEKHG1 PER2 RRP12 CACNA1H AGTPBP1 UNC13B FRAS1 SORBS2 SCAF8 PPP6R1 WDR47 BTBD7 MAST1 RIMBP2 SPEN CEP170B ZMYM3 | 1.62e-11 | 407 | 305 | 22 | 12693553 | |
| Pubmed | MYT1L ERBB3 DCAF6 ATP6V0A1 CRIM1 IQSEC2 ZMYND8 ZEB2 BRWD3 FN3K PTPN13 PTPRK OTOF ASTN2 TAOK1 CAP2 AGTPBP1 UNC13B PITHD1 XRN2 SORBS2 FN1 TAF1C APBA2 ZBTB47 CACHD1 DZIP1 RBCK1 WDR47 ARG2 LIMK1 ASCL1 YLPM1 SENP6 MAST1 APPL1 ZNF76 KDM4A | 7.07e-11 | 1285 | 305 | 38 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZMYND8 USP19 BAP1 FANCD2 RRP12 TAOK1 AGTPBP1 XRN2 DNAJC13 SORBS2 ZEB1 SCAF8 EML4 KLC2 ARHGAP35 SRRT GTF2I GTF3C1 ZNF335 YLPM1 SENP6 SMARCC2 APPL1 TNKS1BP1 IRS2 BUB3 SPEN ZMYM3 | 3.31e-10 | 774 | 305 | 28 | 15302935 |
| Pubmed | ZMYND8 RGPD1 RUSC1 BIRC6 ZEB2 BAP1 PTPN13 KIF11 DNAJC13 ZEB1 RGPD8 POLRMT PPP6R1 GTF2I GTF3C1 TNKS1BP1 IRS2 CNOT1 ZMYM3 TP53BP2 | 1.16e-09 | 418 | 305 | 20 | 34709266 | |
| Pubmed | MAG ATP6V1A HTRA1 ATP6V0A1 RPN1 IQSEC2 ARHGEF17 RTN1 TUFM NLGN3 DLD AGTPBP1 CNTN1 CACNA1A PITPNM2 FLNC DNAJC13 SORBS2 SGIP1 FN1 DOCK8 KLC2 ARHGAP35 WDR47 SRRT ARHGDIA SHANK2 RNPEP ARVCF VPS35 MAST1 SMARCC2 RIMBP2 TNKS1BP1 PCDH1 CNOT1 CEP170B TP53BP2 | 1.44e-09 | 1431 | 305 | 38 | 37142655 | |
| Pubmed | ATP6V1A ERBB4 RPN1 TSPOAP1 IQSEC2 RGPD1 PER1 HMGCS1 BIRC6 RTN1 KCND2 DLD MAPRE2 CACNA1A PITPNM2 SORBS2 SGIP1 SLC4A8 RGPD8 APBA2 KLC2 PPP6R1 ARHGAP35 TAB3 WDR47 SHANK2 CELSR2 SMARCC2 UBR3 APPL1 CNOT1 PCDH8 CEP170B | 2.31e-09 | 1139 | 305 | 33 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB4 LSG1 IQSEC2 PAK4 MPDZ PFKFB2 ARHGEF17 LYST DENND2B PLEKHG1 PTPN13 SYNE2 PLK1 KIF11 SORBS2 DSC2 KLC2 EPB41L5 DZIP1 LBR TAB3 SRRT LIMK1 SRPK3 TNKS1BP1 IRS2 CEP170B TP53BP2 | 3.48e-09 | 861 | 305 | 28 | 36931259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPN1 MYO9B LSG1 BIRC6 TUFM NFKB2 RRP12 PLK1 MAPRE2 PHIP KIF11 FLNC XRN2 DNAJC13 FN1 EML4 TAF1C RPP30 POLRMT EPB41L5 OCRL LBR WDR47 SRRT ARHGDIA GTF2I ARAP3 GTF3C1 ARVCF AIFM1 VPS35 SMARCC2 BUB3 ZMYM3 TP53BP2 | 1.31e-08 | 1353 | 305 | 35 | 29467282 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | WSB1 ATP6V1A SPG7 MYO9B ZMYND8 GDF9 PTPRK PTPRO SYNE2 RRP7A TAOK1 AKT1 PLK1 CNTN1 DNAJC13 SORBS2 RASA1 NOA1 TAF1C APBA2 KLC2 RELA PPP6R1 ARHGDIA MIDN GTF3C1 FRZB CARD11 PCDH8 CDH13 TP53BP2 | 2.25e-08 | 1124 | 305 | 31 | 21900206 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 HTRA1 ATP6V0A1 GALNS CRIM1 RPN1 AXL ITGA5 ITGA7 ITGB4 USP19 PTPRK RRP12 COL3A1 P4HA2 FAT4 FRAS1 POMGNT1 RELA CACHD1 PPP6R1 MINPP1 LBR GTF3C1 CELSR2 LNPEP CSPG4 VPS35 TNKS1BP1 ATP2A3 CDH13 ATP6V0A2 | 2.93e-08 | 1201 | 305 | 32 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATP6V1A DCAF6 OBSCN SMOC2 PDE10A DENND2B BRWD3 NLGN3 BMPR1B PTPN13 ASTN2 CACNA1H MMP16 CAP2 BRMS1 PRUNE2 PITPNM2 DNAJC13 SPATA6 RASA1 SCAF8 UVSSA G2E3 ARHGAP35 TARS2 ABCG1 GTF2I SHANK2 GTF3C1 TESMIN MAST1 NRG3 FBXO21 PCDH1 CNOT1 CEP170B | 4.40e-08 | 1489 | 305 | 36 | 28611215 |
| Pubmed | BIRC6 TUFM RRP12 SYNE2 DLD RRP7A PHIP RAD21 FLNC XRN2 FN1 POLRMT ARHGDIA GTF2I GTF3C1 RNPEP YLPM1 SMARCC2 TNKS1BP1 SPEN CNOT1 ZMYM3 | 9.64e-08 | 653 | 305 | 22 | 22586326 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPN1 LSG1 ZMYND8 ZNF207 TUFM PTPN13 PTPRO RRP12 ALPG FLNC XRN2 DNAJC13 SORBS2 SMPD4 MRPL45 LBR ARHGAP35 MRPL4 SRRT GTF3C1 GYS1 YLPM1 SMARCC2 TNKS1BP1 BUB3 SPEN CNOT1 TNXB ZMYM3 | 1.20e-07 | 1082 | 305 | 29 | 38697112 |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | AXIN2 PTPN13 NFKB2 KIF11 FLNC FOXN2 EPB41L5 RELA CACHD1 CNOT1 | 2.12e-07 | 128 | 305 | 10 | 25332235 |
| Pubmed | PAK4 ITGA5 BIRC6 FANCD2 PTPN13 PTPRK RRP12 SYNE2 PLK1 MAPRE2 CAP2 AGTPBP1 DNAJC13 SMPD4 RELA CACHD1 PPP6R1 TARS2 PAF1 TAB3 SLC12A4 ARVCF AIFM1 LNPEP YLPM1 UBR3 CNOT1 TP53BP2 | 2.18e-07 | 1049 | 305 | 28 | 27880917 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | RPN1 PAK4 TAOK1 PLK1 KIF11 RAD21 DNAJC13 SCAF8 PAF1 GTF2I SMARCC2 CNOT1 | 2.76e-07 | 203 | 305 | 12 | 22083510 |
| Pubmed | RPN1 MPDZ ZNF207 TUFM FANCD2 HMCN2 RRP12 DLD PLK1 UNC13B XRN2 NOA1 RPP30 APBA2 POLRMT PPP6R1 MRPL45 LBR TARS2 PAF1 RIOX2 MRPL4 ARHGDIA GTF2I GTF3C1 AIFM1 BTBD7 NT5DC2 GYS1 VPS35 SMARCC2 BUB3 | 3.16e-07 | 1335 | 305 | 32 | 29229926 | |
| Pubmed | LSG1 RGPD1 MPDZ RTN1 PTPN13 NFKB2 PPP6R1 ARHGAP35 TBC1D8 TNKS1BP1 CEP170B TP53BP2 | 3.77e-07 | 209 | 305 | 12 | 36779422 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP6V1A ATP6V0A1 RPN1 LSG1 ZNF207 TUFM USP19 FANCD2 RRP12 CC2D2A DLD RRP7A PHIP KIF11 RAD21 XRN2 SMC6 POLRMT LBR TARS2 RIOX2 MRPL4 SRRT ARHGDIA GTF2I GTF3C1 RNPEP AIFM1 NT5DC2 VPS35 BUB3 SPEN CNOT1 | 4.42e-07 | 1425 | 305 | 33 | 30948266 |
| Pubmed | ERCC2 CRIM1 AXL OBSCN TUFM RYR1 NFKB2 HACE1 FLNC FN1 SLC22A18AS IRS2 | 4.85e-07 | 214 | 305 | 12 | 22199357 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | RPN1 TSPOAP1 MYO9B LSG1 LYST RYR1 TAOK1 MMP12 PHIP CACNA1A DSC2 POMGNT1 SH3D21 TBC1D8 SHANK2 L3MBTL1 ZNF335 CATSPERB TNXB | 5.34e-07 | 552 | 305 | 19 | 10737800 |
| Pubmed | 6.68e-07 | 3 | 305 | 3 | 17478723 | ||
| Pubmed | Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation. | 6.68e-07 | 3 | 305 | 3 | 25830382 | |
| Pubmed | 6.68e-07 | 3 | 305 | 3 | 17227585 | ||
| Pubmed | 6.68e-07 | 3 | 305 | 3 | 15629714 | ||
| Pubmed | 7.12e-07 | 83 | 305 | 8 | 11114734 | ||
| Pubmed | 7.19e-07 | 146 | 305 | 10 | 27068509 | ||
| Pubmed | ATP6V0A1 RPN1 LSG1 PAK4 MPDZ PLEKHG1 PTPN13 RRP12 SYNE2 DLD AGTPBP1 RAD21 FRAS1 DNAJC13 DSC2 RPP30 POLRMT EPB41L5 SMPD4 PPP6R1 MRPL45 DZIP1 LBR TARS2 PAF1 MRPL4 TBC1D8 AIFM1 LNPEP NT5DC2 VPS35 OCLN ATP6V0A2 | 1.13e-06 | 1487 | 305 | 33 | 33957083 | |
| Pubmed | AXL RGPD1 ITGA5 SMOC2 GPKOW RYR1 ITPA SYNE2 RRP7A TRAPPC11 FAT4 VTN NUBP2 MANBAL ARVCF GYS1 SMARCC2 IRS2 SPEN CNOT1 | 1.14e-06 | 638 | 305 | 20 | 31182584 | |
| Pubmed | RPN1 ZMYND8 RGPD1 GATA3 ZEB2 BAP1 HDAC3 NFKB2 RRP12 SYNE2 DLD RAD21 BRMS1 XRN2 ZEB1 SCAF8 RELA PPP6R1 LBR TAB3 MRPL4 SRRT MIDN GTF2I GTF3C1 AIFM1 YLPM1 GATAD1 SMARCC2 SPEN CNOT1 ZMYM3 | 1.37e-06 | 1429 | 305 | 32 | 35140242 | |
| Pubmed | POP7 ATP6V1A RPN1 LSG1 ZNF207 GPKOW TUFM ITPA RRP7A TAOK1 GNL1 AGTPBP1 UNC13B VTN FN1 EML4 TAF1C RPP30 EPB41L5 LBR RIOX2 SRRT ARHGDIA GTF2I AIFM1 YLPM1 SMARCC2 ROS1 BUB3 FBXO21 CNOT1 | 1.66e-06 | 1371 | 305 | 31 | 36244648 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | ZMYND8 HDAC3 RRP12 SYNE2 PHIP BRMS1 PPP6R1 AIFM1 YLPM1 GATAD1 APPL1 ATP2A3 ZMYM3 | 1.95e-06 | 289 | 305 | 13 | 23752268 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPEG ZMYND8 OBSCN FN3K RRP12 TAOK1 PLK1 FN1 POLRMT KLC2 MIDN GTF3C1 VPS35 KDM4A IRS2 ATP2A3 CNOT1 | 2.32e-06 | 497 | 305 | 17 | 36774506 |
| Pubmed | ERBB4 DCAF6 ERCC2 HTRA1 LSG1 ZMYND8 PER1 BRWD3 TUFM ITIH4 FANCD2 HMCN2 PHIP AGTPBP1 DSC2 FAT3 TAF1C APBA2 POLRMT PPP6R1 LBR ARG2 NT5DC2 SMARCC2 IRS2 CEP170B ZMYM3 | 2.34e-06 | 1116 | 305 | 27 | 31753913 | |
| Pubmed | PAK4 MPDZ PFKFB2 BIRC6 PLEKHG1 PTPN13 PLK1 RAD21 SORBS2 DOCK8 KLC2 PPP6R1 IRS2 CNOT1 CEP170B TP53BP2 | 2.51e-06 | 446 | 305 | 16 | 24255178 | |
| Pubmed | 2.65e-06 | 4 | 305 | 3 | 21382453 | ||
| Pubmed | 2.65e-06 | 4 | 305 | 3 | 18270579 | ||
| Pubmed | 2.65e-06 | 4 | 305 | 3 | 32219160 | ||
| Pubmed | 2.65e-06 | 4 | 305 | 3 | 17904217 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ATP6V0A1 IQSEC2 ZMYND8 RUSC1 ITGB4 USP19 ITPA PLK1 MAPRE2 CAP2 KIF11 DXO ZEB1 KLC2 EPB41L5 TRMT1 TARS2 NUBP2 MRPL4 WDR91 ARHGDIA SLC12A4 RNPEP FBXO21 | 2.69e-06 | 925 | 305 | 24 | 28986522 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATP6V1A LSG1 PAK4 ZMYND8 GPKOW RTN1 PTPN13 RRP12 DLD MAPRE2 KIF11 RAD21 NEBL PPP6R1 OCRL ARHGAP35 PAF1 ARHGDIA GTF2I YLPM1 SENP6 TNKS1BP1 IRS2 TP53BP2 | 3.17e-06 | 934 | 305 | 24 | 33916271 |
| Pubmed | EPHB2 ATP6V0A1 GATA3 PFKFB2 PDE10A DENND2B IFT43 NME8 DQX1 AKT1 IQUB SGIP1 SPATA6 NEBL NOA1 MINPP1 ERN2 ARHGDIA ALKBH3 GATAD1 | 3.41e-06 | 686 | 305 | 20 | 29987050 | |
| Pubmed | EPHB2 ERBB4 MPDZ PDE10A FN3K KCND2 DLD ASTN2 CACNA1A SGIP1 SLC4A8 AATK ARVCF AIFM1 PCDH8 | 3.53e-06 | 405 | 305 | 15 | 38187761 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPN1 LSG1 SCYL1 BIRC6 RTN1 TUFM USP19 ITPA FANCD2 HDAC3 RRP12 SYNE2 ACOT2 PLK1 GNL1 PHIP RAD21 RGPD8 NOA1 FASTKD1 POLRMT TRMT1 SMPD4 MRPL45 OCRL LBR TARS2 NUBP2 ARG2 MRPL4 AIFM1 NT5DC2 | 3.57e-06 | 1496 | 305 | 32 | 32877691 |
| Pubmed | Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells. | 3.90e-06 | 13 | 305 | 4 | 18036209 | |
| Pubmed | Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. | 4.18e-06 | 28 | 305 | 5 | 25993318 | |
| Pubmed | RPN1 LSG1 ADAM7 RGPD1 PDE10A LYST ZEB2 TUFM BMPR1B CLCN5 SYNE2 CC2D2A PDIA2 DLD KIF11 RGPD5 FLNC RGPD8 PCDHGB3 SH3D21 SHANK2 GTF3C1 SLC12A4 TESMIN CSPG4 VPS35 YLPM1 SMARCC2 SPEN ATP2A3 HCLS1 | 4.62e-06 | 1442 | 305 | 31 | 35575683 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ZMYND8 ITGA7 BIRC6 USP19 TAOK1 CNTN1 ALPG FOXN2 FN1 PRAMEF22 RPP30 GPN2 ZNF335 BUB3 | 4.71e-06 | 363 | 305 | 14 | 14691545 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | POP7 MYO9B LSG1 FANCD2 RRP12 XRN2 NOA1 RPP30 TRMT1 PPP6R1 SRRT YLPM1 TNKS1BP1 CNOT1 | 4.86e-06 | 364 | 305 | 14 | 24778252 |
| Pubmed | 5.42e-06 | 14 | 305 | 4 | 37414855 | ||
| Pubmed | ERBB3 LSG1 MPDZ TUFM RNF128 FRAS1 XRN2 VTN SCAF8 EML4 NOA1 POLRMT PPP6R1 TARS2 RGS3 SRRT ARAP3 GTF3C1 ARVCF | 5.78e-06 | 650 | 305 | 19 | 38777146 | |
| Pubmed | HTRA1 ZMYND8 DENND2B ZEB2 CAP2 FLNC FN1 DOCK8 RGS3 SLC12A4 RNPEP LNPEP CSPG4 VPS35 YLPM1 ZNF76 PCDH1 TP53BP2 | 5.85e-06 | 591 | 305 | 18 | 15231748 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ERCC2 IQSEC2 PAK4 SCYL1 PER1 GPKOW HDAC3 NFKB2 AGTPBP1 PITPNM2 RELA PPP6R1 OCRL PAF1 WDR91 SRRT ARAP3 SHANK2 BTBD7 GPN2 GYS1 TNKS1BP1 IRS2 BUB3 CNOT1 | 6.06e-06 | 1038 | 305 | 25 | 26673895 |
| Pubmed | RPN1 LSG1 SCYL1 TUFM GNL1 KIF11 FRAS1 XRN2 TENT4A KLC2 TRMT1 PAF1 SRRT GTF2I AIFM1 GYS1 VPS35 YLPM1 BUB3 | 6.17e-06 | 653 | 305 | 19 | 33742100 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GDAP2 IQSEC2 PAK4 SCYL1 ZNF207 PFKFB2 IFT43 NME8 PTPN13 WDR35 PLK1 MAPRE2 P4HA2 XRN2 DNAJC13 VTN EML4 SMC6 PCARE OCRL ARHGDIA GTF2I GYS1 APPL1 TNKS1BP1 DCAF11 BUB3 CNOT1 TP53BP2 | 6.43e-06 | 1321 | 305 | 29 | 27173435 |
| Pubmed | 6.59e-06 | 5 | 305 | 3 | 33539324 | ||
| Pubmed | 6.59e-06 | 5 | 305 | 3 | 12840049 | ||
| Pubmed | 6.59e-06 | 5 | 305 | 3 | 21429937 | ||
| Pubmed | Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. | 6.59e-06 | 5 | 305 | 3 | 21407808 | |
| Pubmed | 6.59e-06 | 5 | 305 | 3 | 38789481 | ||
| Pubmed | 6.59e-06 | 5 | 305 | 3 | 9614184 | ||
| Pubmed | 7.03e-06 | 53 | 305 | 6 | 34026424 | ||
| Pubmed | 7.34e-06 | 15 | 305 | 4 | 15366018 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | LSG1 PAK4 PTPN13 AGTPBP1 FLNC DNAJC13 EML4 TAF1C SMC6 RPP30 EPB41L5 OCRL ARHGAP35 PAF1 RIOX2 YLPM1 MTRR BUB3 SPEN CNOT1 | 7.54e-06 | 724 | 305 | 20 | 36232890 |
| Pubmed | ARHGEF17 TUFM OTOF XRN2 RGPD8 FAT3 PCARE GTF2I ZNF335 VPS35 SMARCC2 | 7.94e-06 | 234 | 305 | 11 | 36243803 | |
| Pubmed | 8.32e-06 | 32 | 305 | 5 | 23154389 | ||
| Pubmed | RPN1 MPDZ TUFM PTPN13 PLK1 RGPD5 ARHGAP35 PAF1 TAB3 GTF2I GTF3C1 YLPM1 TNKS1BP1 BUB3 SPEN CNOT1 TP53BP2 | 8.59e-06 | 549 | 305 | 17 | 38280479 | |
| Pubmed | 9.01e-06 | 153 | 305 | 9 | 10718198 | ||
| Pubmed | Cdk5 phosphorylation of ErbB4 is required for tangential migration of cortical interneurons. | 9.71e-06 | 16 | 305 | 4 | 24142862 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | RPN1 MPDZ ZNF207 USP19 BAP1 PLK1 KIF11 RGPD5 UNC13B FLNC P4HA2 TAF1C APBA2 PPP6R1 MRPL45 GTF2I GYS1 VPS35 YLPM1 RIMBP2 KDM4A DCAF11 BUB3 CNOT1 | 1.07e-05 | 1005 | 305 | 24 | 19615732 |
| Pubmed | RPN1 ZMYND8 ZNF207 TUFM AXIN2 NFKB2 DLD PLK1 KIF11 FLNC XRN2 FN1 SMC6 POLRMT TARS2 SRRT GTF2I AIFM1 YLPM1 BUB3 CNOT1 | 1.14e-05 | 809 | 305 | 21 | 32129710 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZMYND8 GATA3 SCYL1 PLK1 SMC6 RPP30 PAF1 SRRT GTF3C1 YLPM1 SMARCC2 TNKS1BP1 SPEN | 1.16e-05 | 341 | 305 | 13 | 32971831 |
| Pubmed | 1.19e-05 | 87 | 305 | 7 | 12465718 | ||
| Pubmed | 1.26e-05 | 17 | 305 | 4 | 33305682 | ||
| Pubmed | The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. | 1.31e-05 | 6 | 305 | 3 | 25915022 | |
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 1.31e-05 | 6 | 305 | 3 | 19893454 | |
| Pubmed | Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids. | 1.31e-05 | 6 | 305 | 3 | 27782124 | |
| Pubmed | 1.31e-05 | 6 | 305 | 3 | 17548654 | ||
| Pubmed | 1.31e-05 | 6 | 305 | 3 | 23611113 | ||
| Pubmed | 1.31e-05 | 6 | 305 | 3 | 19126672 | ||
| Pubmed | 1.31e-05 | 6 | 305 | 3 | 1694173 | ||
| Pubmed | ERBB4 HTRA1 SPP1 CACNA1H MMP16 EML4 BEAN1 APBA2 SMPD4 RGS3 MRPL4 ABCG1 SHANK2 AIFM1 NT5DC2 VPS35 FBXO21 | 1.33e-05 | 568 | 305 | 17 | 9110174 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | POP7 ATP6V1A ERCC2 LSG1 TUFM BAP1 RRP12 PLK1 TRAPPC11 XRN2 TAF1C RPP30 POLRMT LBR MRPL4 | 1.37e-05 | 454 | 305 | 15 | 33226137 |
| Pubmed | ATP6V1A ATP6V0A1 RTN1 KCND2 TAOK1 CAP2 CACNA1A SGIP1 SHANK2 VPS35 RIMBP2 TNKS1BP1 CEP170B | 1.40e-05 | 347 | 305 | 13 | 17114649 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ERBB3 RPN1 SPP1 AXL SPEG ZNF207 TUFM CLCN5 PTPRK DLD TAOK1 AKT1 COL3A1 PITHD1 FLNC FN1 DSC2 NOA1 FASTKD1 POMGNT1 LBR TARS2 SRRT CELSR2 AIFM1 LNPEP NT5DC2 CSPG4 VPS35 SMARCC2 | 1.40e-05 | 1451 | 305 | 30 | 30550785 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | ATP6V1A RPN1 MPDZ ZNF207 HMGCS1 BIRC6 TUFM FANCD2 RRP12 RGPD5 RPP30 PPP6R1 LBR GTF3C1 AIFM1 VPS35 BUB3 | 1.42e-05 | 571 | 305 | 17 | 37167062 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPN1 MYO9B BIRC6 RRP12 DLD RRP7A PLK1 AGTPBP1 RAD21 XRN2 DNAJC13 SMC6 RPP30 POLRMT RIOX2 SRRT GTF3C1 AIFM1 BUB3 CNOT1 | 1.49e-05 | 759 | 305 | 20 | 35915203 |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | ERBB4 HTRA1 SPP1 CACNA1H MMP16 EML4 BEAN1 APBA2 SMPD4 RGS3 MRPL4 ABCG1 SHANK2 AIFM1 NT5DC2 VPS35 FBXO21 | 1.52e-05 | 574 | 305 | 17 | 8619474 |
| Pubmed | 1.64e-05 | 126 | 305 | 8 | 17897319 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ATP6V1A ERCC2 RPN1 ZMYND8 HMGCS1 TUFM ITIH4 BAP1 RRP12 DLD RRP7A TAOK1 PLK1 MAPRE2 PHIP RAD21 XRN2 SCAF8 SMPD4 LBR PAF1 NUBP2 MRPL4 GTF2I AIFM1 NT5DC2 GYS1 BUB3 | 1.69e-05 | 1318 | 305 | 28 | 30463901 |
| Pubmed | 1.76e-05 | 62 | 305 | 6 | 19367581 | ||
| Pubmed | 1.82e-05 | 167 | 305 | 9 | 22159717 | ||
| Pubmed | RPN1 LSG1 PAK4 MPDZ PTPN13 MAPRE2 PITHD1 DSC2 EPB41L5 CACHD1 OCRL LBR TBC1D8 ARHGDIA AIFM1 TNKS1BP1 IRS2 OCLN CNOT1 | 1.90e-05 | 708 | 305 | 19 | 39231216 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | TYRO3 BMPR1B SYNE2 PHIP CNTN1 UNC13B SRRT LIMK1 CELSR2 VPS35 YLPM1 IRS2 CNOT1 | 1.94e-05 | 358 | 305 | 13 | 32460013 |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | HDAC3 PTPRK PLK1 CNTN1 RAD21 XRN2 DSC2 SCAF8 GTF2I CELSR2 OCLN TP53BP2 | 1.97e-05 | 307 | 305 | 12 | 37499664 |
| Pubmed | 2.03e-05 | 19 | 305 | 4 | 27306493 | ||
| Pubmed | Pericytes are required for blood-brain barrier integrity during embryogenesis. | 2.03e-05 | 19 | 305 | 4 | 20944625 | |
| Pubmed | ATP6V1A LSG1 SCYL1 BIRC6 TUFM USP19 PTPN13 FAT4 DNAJC13 FN1 DSC2 SMC6 EPB41L5 RELA OCRL LBR GTF2I OCLN SPEN ATP6V0A2 | 2.08e-05 | 777 | 305 | 20 | 35844135 | |
| Interaction | TOP3B interactions | ERCC2 SPG7 MYO9B SPEG OBSCN PER1 ITGA5 BIRC6 LYST ITGB4 TUFM RYR1 AXIN2 BAP1 PLEKHG1 LIME1 PER2 NFKB2 RRP12 AKT1 CACNA1H FGFR2 UNC13B PITPNM2 FLNC FRAS1 SLC37A3 POLRMT TRMT1 POMGNT1 PPP6R1 ARHGAP35 IDUA AATK GTF2I ARAP3 SHANK2 CELSR2 SLC12A4 ARVCF BTBD7 ZNF335 CSPG4 TNKS1BP1 KDM4A IRS2 SPEN ATP2A3 CNOT1 CEP170B | 5.44e-08 | 1470 | 305 | 50 | int:TOP3B |
| Interaction | LGALS8 interactions | ATP6V0A1 ITGA5 ITGA7 CLCN5 PTPRK PDIA2 DNAJC13 FN1 ARHGDIA SLC12A4 LNPEP CSPG4 ATP6V0A2 | 2.61e-06 | 174 | 305 | 13 | int:LGALS8 |
| Interaction | RDX interactions | EPHB2 RTN1 TUFM BAP1 KIF11 FLNC NEBL OCRL ARHGDIA ARHGDIG MIDN AATK GTF2I AIFM1 TNKS1BP1 OCLN | 7.46e-06 | 284 | 305 | 16 | int:RDX |
| Interaction | VASP interactions | POP7 MPDZ RTN1 AKT1 APBB1IP FN1 NEBL PCARE PPP6R1 OCRL ARHGAP35 TNKS1BP1 IRS2 FYB1 CEP170B TP53BP2 | 1.15e-05 | 294 | 305 | 16 | int:VASP |
| Interaction | YWHAH interactions | LSG1 SPEG IQSEC2 PAK4 MPDZ PFKFB2 ARHGEF17 LYST DENND2B BAP1 FANCD2 PLEKHG1 PTPN13 SYNE2 CC2D2A DLD TAOK1 PLK1 KIF11 TRAPPC11 SORBS2 FN1 DSC2 KLC2 EPB41L5 DZIP1 LBR TAB3 SRRT RNPEP MAST1 APPL1 TNKS1BP1 IRS2 CEP170B TP53BP2 | 1.19e-05 | 1102 | 305 | 36 | int:YWHAH |
| Interaction | RGPD4 interactions | 1.64e-05 | 22 | 305 | 5 | int:RGPD4 | |
| Interaction | FANCI interactions | EPHB2 AXL BAP1 FANCD2 TYRO3 AKT1 FGFR2 NUBP2 AATK L3MBTL1 AIFM1 VPS35 SENP6 | 2.33e-05 | 213 | 305 | 13 | int:FANCI |
| Interaction | DDB1 interactions | WSB1 DCAF6 ZMYND8 GATA3 ZEB2 BRWD3 BAP1 FANCD2 HDAC3 MYO3B WDR35 PHIP RAD21 FLNC VTN UVSSA POLRMT PAF1 WDR91 SRRT MIDN GTF2I AIFM1 VPS35 DCAF11 BUB3 | 2.37e-05 | 697 | 305 | 26 | int:DDB1 |
| Interaction | DKKL1 interactions | 4.85e-05 | 111 | 305 | 9 | int:DKKL1 | |
| Interaction | C2CD4B interactions | 4.98e-05 | 44 | 305 | 6 | int:C2CD4B | |
| Interaction | LGALS1 interactions | DCAF6 ATP6V0A1 ITGA5 ITGA7 FANCD2 NLGN3 PTPRK FAT4 FRAS1 FN1 FAT3 GTF2I CELSR2 LNPEP CSPG4 ATP6V0A2 | 5.04e-05 | 332 | 305 | 16 | int:LGALS1 |
| Interaction | RPS14P3 interactions | 6.15e-05 | 15 | 305 | 4 | int:RPS14P3 | |
| Interaction | PIK3R1 interactions | EPHB2 ERBB3 ERBB4 PDGFB SPP1 AXL TYRO3 HDAC3 NLGN3 PTPRK AKT1 FGFR2 RASA1 SH2D2A SMARCC2 APPL1 IRS2 OCLN | 6.19e-05 | 412 | 305 | 18 | int:PIK3R1 |
| Interaction | CMA1 interactions | 6.44e-05 | 46 | 305 | 6 | int:CMA1 | |
| Interaction | RAB35 interactions | EPHB2 RPN1 PAK4 ITGA5 ITPA FANCD2 PTPN13 SYNE2 PLK1 FN1 DSC2 EPB41L5 SMPD4 CACHD1 OCRL DZIP1 LBR MIDN SLC12A4 LNPEP TNKS1BP1 OCLN | 6.69e-05 | 573 | 305 | 22 | int:RAB35 |
| Interaction | ARL8B interactions | ATP6V1A ATP6V0A1 BIRC6 USP19 FANCD2 PTPN13 KLC2 LBR VPS35 GATAD1 APPL1 OCLN | 6.85e-05 | 204 | 305 | 12 | int:ARL8B |
| Interaction | VCL interactions | ATP6V1A PAK4 MPDZ ITGA5 BIRC6 BAP1 FANCD2 PHIP KIF11 SORBS2 FN1 NEBL EPB41L5 NUBP2 TNKS1BP1 | 6.89e-05 | 305 | 305 | 15 | int:VCL |
| Interaction | EMD interactions | ERBB3 RPN1 LSG1 AXL GPR152 GATA3 SCYL1 RTN1 FANCD2 TYRO3 HDAC3 LIME1 SYNE2 PLK1 FRAS1 ZEB1 DSC2 TRIM42 UVSSA POLRMT SMPD4 MRPL45 LBR MIDN KASH5 SMARCC2 ROS1 | 7.24e-05 | 789 | 305 | 27 | int:EMD |
| Cytoband | 19q13.1 | 3.32e-05 | 55 | 305 | 5 | 19q13.1 | |
| GeneFamily | Fibronectin type III domain containing | EPHB2 TSPOAP1 AXL OBSCN ITGB4 TYRO3 PTPRK PTPRO ASTN2 USH2A CNTN1 NPHS1 FN1 TRIM42 VWA1 ROS1 TNXB | 9.68e-12 | 160 | 218 | 17 | 555 |
| GeneFamily | PDZ domain containing | 9.65e-05 | 152 | 218 | 9 | 1220 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.14e-04 | 40 | 218 | 5 | 321 | |
| GeneFamily | Non-clustered protocadherins | 3.51e-04 | 12 | 218 | 3 | 21 | |
| GeneFamily | WD repeat domain containing | WSB1 DCAF6 LYST BRWD3 WDR35 PHIP EML4 WDR47 WDR91 DCAF11 BUB3 | 3.51e-04 | 262 | 218 | 11 | 362 |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 8.55e-04 | 4 | 218 | 2 | 1096 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 1.23e-03 | 18 | 218 | 3 | 498 | |
| GeneFamily | Secreted frizzled-related proteins | 1.41e-03 | 5 | 218 | 2 | 733 | |
| GeneFamily | Ankyrin repeat domain containing|NF-kappa B complex subunits | 1.41e-03 | 5 | 218 | 2 | 1254 | |
| GeneFamily | V-type ATPases | 2.56e-03 | 23 | 218 | 3 | 415 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.90e-03 | 24 | 218 | 3 | 891 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.92e-03 | 7 | 218 | 2 | 1299 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 3.27e-03 | 25 | 218 | 3 | 565 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.43e-03 | 161 | 218 | 7 | 593 | |
| GeneFamily | Sterile alpha motif domain containing | 4.24e-03 | 88 | 218 | 5 | 760 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | ATP6V0A1 BRWD3 FANCD2 HDAC3 WDR35 AKT1 PLK1 KIF11 SGIP1 SLC4A8 TRMT1 POMGNT1 CEP170B PRODH | 4.55e-08 | 187 | 305 | 14 | M6807 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | ERBB3 HTRA1 SPP1 GATA3 PTPRK NFKB2 ACOT2 FGFR2 RNF128 CNTN1 FN1 TRMT1 ARG2 CLCA3P OCLN | 7.33e-07 | 270 | 305 | 15 | M19432 |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | MYT1L ADCYAP1 KCND2 PTPRO PDIA2 ASTN2 CNTN1 SGIP1 ARHGDIG SLC18A3 MAST1 | 3.14e-06 | 161 | 305 | 11 | M40214 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | MYT1L GATA3 PDE10A FN3K ASTN2 CNTN1 PRUNE2 SLC4A8 KLC2 ARG2 ARHGDIG ABCG1 SHANK2 SLC18A3 MAST1 RIMBP2 | 9.52e-06 | 375 | 305 | 16 | M45799 |
| Coexpression | LOPEZ_MBD_TARGETS | MAG CRIM1 RPN1 SPP1 AXL ITGA5 PCDH12 RYR1 RRP12 DLD KIF11 ATG9B VTN FN1 DSC2 TENT4A POLRMT VWA1 RGS3 NUBP2 ARHGDIA AATK SLC12A4 RNPEP SMARCC2 HCLS1 TP53BP2 | 2.13e-05 | 953 | 305 | 27 | M4120 |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN | WSB1 ATP6V1A GDAP2 PER1 SMOC2 SUOX APBB1IP ALPG FN1 TAF1C FYB1 | 2.45e-05 | 200 | 305 | 11 | M3833 |
| Coexpression | GSE3982_MAC_VS_BASOPHIL_UP | RTN1 ZEB2 ADCYAP1 MYOZ1 CACNA1H FASTKD1 MRPL4 RNPEP CSPG4 MTRR DCAF11 | 2.45e-05 | 200 | 305 | 11 | M5496 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HTRA1 CRIM1 PDGFB SPEG GATA3 PDE10A PCDH12 LYST DENND2B ZEB2 PLEKHG1 PER2 PTPRO SHE TAOK1 FOXN2 SGIP1 NEBL MMP23B CLCA3P ARVCF LNPEP UBR3 SLC2A12 ATP2A3 | 2.55e-05 | 854 | 305 | 25 | M1533 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | ERBB3 HTRA1 SPP1 GATA3 PTPRK NFKB2 FGFR2 RNF128 CNTN1 FN1 TRMT1 ARG2 OCLN | 3.18e-05 | 284 | 305 | 13 | MM987 |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | ERBB3 PDE10A ZEB2 NLGN3 MMP16 CNTN1 RAD21 ASCL1 MAST1 FBXO21 | 4.56e-05 | 177 | 305 | 10 | M2115 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ATP6V1A HTRA1 ATP6V0A1 GALNS MYO9B SPEG CD300A SMOC2 FN3K TYRO3 PTPN13 CLCN5 PTPRO NFKB2 MMP12 RNF128 APBB1IP VTN SPATA6 RASA1 DOCK8 MMP23B CACHD1 NLRP6 WDR91 ARHGDIA ABCG1 FRZB CARD11 HCLS1 PRODH | 5.82e-05 | 1242 | 305 | 31 | M1920 |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 5.88e-05 | 147 | 305 | 9 | MM414 | |
| Coexpression | AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4 | CRIM1 HMGCS1 NFKB2 SYNE2 FGFR2 SORBS2 TNKS1BP1 IRS2 OCLN TP53BP2 | 6.33e-05 | 184 | 305 | 10 | M39135 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | MYT1L TSPOAP1 PTPN13 PTPRK PTPRO PDIA2 CAP2 AGTPBP1 CACNA1A FAT3 RELA WDR47 SHANK2 CELSR2 MAST1 RIMBP2 IRS2 | 6.61e-05 | 488 | 305 | 17 | M39104 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | ERBB3 ERBB4 ZMYND8 GATA3 ITGA7 RTN1 BMPR1B AK5 ACSM5 ASTN2 CACNA1H HEMK1 SFRP4 SLC4A8 NEBL ARHGAP35 ABCG1 TESMIN ASCL1 CATSPERB ATP2A3 | 7.95e-05 | 699 | 305 | 21 | M4960 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | EPHB2 TSPOAP1 MYO9B ITGA7 ARHGEF17 SUOX MAPRE2 FLNC ARHGAP35 GTF2I CELSR2 GYS1 | 1.04e-04 | 276 | 305 | 12 | M3063 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.07e-04 | 196 | 305 | 10 | M3008 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | LIME1 CARNS1 CAP2 SLC37A3 FASTKD1 SH2D2A RBCK1 GTF2I APPL1 CEP170B | 1.21e-04 | 199 | 305 | 10 | M3585 |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 1.21e-04 | 199 | 305 | 10 | M3599 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.21e-04 | 199 | 305 | 10 | M6645 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | PAK4 GATA3 PER1 SMOC2 DENND2B FGFR2 COL3A1 POMGNT1 IRS2 PCDH1 | 1.21e-04 | 199 | 305 | 10 | M6538 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | ATP6V0A1 CRIM1 DENND2B ZEB2 TAOK1 AKT1 PI16 SMC6 CLCA3P GYS1 | 1.21e-04 | 199 | 305 | 10 | M2155 |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.26e-04 | 200 | 305 | 10 | M9484 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_DN | 1.26e-04 | 200 | 305 | 10 | M4899 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP | ATP6V0A1 PDGFB AXL ITGA5 PDIA2 KIF11 ATG9B XRN2 SPATA6 MRPL45 | 1.26e-04 | 200 | 305 | 10 | M8264 |
| Coexpression | GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN | 1.26e-04 | 200 | 305 | 10 | M3933 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 1.26e-04 | 200 | 305 | 10 | M8851 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 1.26e-04 | 200 | 305 | 10 | M8843 | |
| Coexpression | GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP | FAM185A PAK4 TUFM UNC13B PITHD1 DNAJC13 TAF1C TRMT1 ARHGDIA APPL1 | 1.26e-04 | 200 | 305 | 10 | M7354 |
| Coexpression | HALLMARK_MYOGENESIS | ERBB3 SPEG ITGA7 ITGB4 DENND2B RYR1 MYOZ1 CACNA1H COL3A1 CDH13 | 1.26e-04 | 200 | 305 | 10 | M5909 |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN | 1.26e-04 | 200 | 305 | 10 | M6536 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | MYT1L ERBB4 HMGCS1 FANCD2 SYNE2 TAOK1 CAP2 ASCL1 ZNF335 FYB1 | 1.26e-04 | 200 | 305 | 10 | M6713 |
| Coexpression | GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP | 1.26e-04 | 200 | 305 | 10 | M9196 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HTRA1 CRIM1 PDGFB SPEG GATA3 PDE10A PCDH12 LYST DENND2B ZEB2 PLEKHG1 PER2 PTPRO SHE TAOK1 FOXN2 SGIP1 NEBL MMP23B ARVCF LNPEP UBR3 SLC2A12 ATP2A3 | 1.27e-04 | 888 | 305 | 24 | MM1018 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_3095_3P_GENES | 1.30e-04 | 67 | 305 | 6 | MM17499 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB3 HTRA1 ITGA5 SMOC2 PDE10A ITGA7 ARHGEF17 PTPRK PTPRO SHE FGFR2 UNC13B FAT4 FN1 DOCK8 MMP23B ARG2 SLC12A4 ASCL1 FRZB CSPG4 MAST1 NRG3 OCLN PCDH8 CDH13 PRODH | 1.58e-04 | 1074 | 305 | 27 | M1941 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ATP6V1A HTRA1 ATP6V0A1 GALNS MYO9B SPEG CD300A SMOC2 FN3K TYRO3 PTPN13 CLCN5 PTPRO NFKB2 MMP12 RNF128 APBB1IP VTN SPATA6 RASA1 DOCK8 MMP23B CACHD1 NLRP6 WDR91 ARHGDIA ABCG1 FRZB CARD11 HCLS1 PRODH | 1.65e-04 | 1316 | 305 | 31 | MM1052 |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 1.94e-04 | 102 | 305 | 7 | M2124 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG SMOC2 ITGA7 CACNA1H CNTN1 PRUNE2 PITPNM2 FLNC FN1 FAT3 ARVCF FRZB CSPG4 SRPK3 GSG1L | 8.56e-12 | 198 | 305 | 15 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 ITIH4 MYOZ1 SYNE2 CACNA1H CAP2 SORBS2 UNC45B FRZB CSPG4 PCDH1 CDH13 | 9.38e-11 | 196 | 305 | 14 | 1d94cecd378a829dd8014fc086d7fca48c953a91 |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 ITIH4 MYOZ1 SYNE2 CACNA1H CAP2 SORBS2 UNC45B FRZB CSPG4 PCDH1 CDH13 | 9.38e-11 | 196 | 305 | 14 | aacec48285bcb7ccf1b538187071885e3602cc49 |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CRIM1 AXL SPEG ITGA7 MYOZ1 CACNA1H CAP2 SORBS2 FN1 ARVCF UNC45B FRZB CSPG4 CDH13 | 1.15e-10 | 199 | 305 | 14 | 9a08c25bb4851ad4ac9db8916422280f71378c2c |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 AXL SPEG ITGA5 ITGA7 SCX MYOZ1 CAP2 PRUNE2 FLNC SORBS2 UNC45B FRZB CSPG4 | 1.23e-10 | 200 | 305 | 14 | 8b80a65b69b36ed405214564b939452c90aa40d6 |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 AXL SPEG ITGA5 ITGA7 SCX MYOZ1 CAP2 PRUNE2 FLNC SORBS2 UNC45B FRZB CSPG4 | 1.23e-10 | 200 | 305 | 14 | 2bc7f462a551292de2501028164573935232f899 |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 NEBL EPB41L5 CACHD1 SHANK2 ROS1 OCLN | 5.79e-10 | 186 | 305 | 13 | 9798428691408e17ff2af2fe2d1b345f074d67e4 |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | ERBB3 ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 SHANK2 ROS1 OCLN | 6.60e-10 | 188 | 305 | 13 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 CACHD1 SHANK2 ROS1 OCLN | 8.55e-10 | 192 | 305 | 13 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | ERBB4 DENND2B CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 CACHD1 SHANK2 OCLN | 8.55e-10 | 192 | 305 | 13 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 MYOZ1 SYNE2 CACNA1H CAP2 PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 9.12e-10 | 193 | 305 | 13 | 5260ac95a15cc43a19909badad0c7e3854da920d |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 MYOZ1 SYNE2 CACNA1H CAP2 PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 9.12e-10 | 193 | 305 | 13 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | AXL SPEG SMOC2 ITGA7 MYOZ1 CACNA1H PRUNE2 FLNC SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.10e-09 | 196 | 305 | 13 | e3c89c5bd674289738d5590ebfd30c605f5156a5 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ITGA5 SMOC2 ITGA7 HMCN2 CACNA1H PRUNE2 FLNC SOST SGIP1 FN1 FAT3 CDH13 | 1.17e-09 | 197 | 305 | 13 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | CRIM1 PDGFB SMOC2 ITGA7 MYOZ1 SUOX CACNA1H CAP2 SORBS2 FRZB CSPG4 ATP2A3 PCDH1 | 1.17e-09 | 197 | 305 | 13 | 98f0184a09563a544f0c2d4df22c9db2fbc95019 |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | AXL SPEG ITGA7 SCX MYOZ1 CAP2 PRUNE2 FLNC SORBS2 FN1 FRZB CSPG4 CDH13 | 1.25e-09 | 198 | 305 | 13 | c82a151f9f1477d4a401457173b8d72af776c137 |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | AXL SPEG ITGA7 SCX MYOZ1 CAP2 PRUNE2 FLNC SORBS2 FN1 FRZB CSPG4 CDH13 | 1.25e-09 | 198 | 305 | 13 | dc63b56bb6291e527b172d603569376286262845 |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CRIM1 AXL SPEG ITGA7 MYOZ1 CACNA1H CAP2 SORBS2 FN1 ARVCF FRZB CSPG4 CDH13 | 1.33e-09 | 199 | 305 | 13 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | ERBB4 CRIM1 CAPN8 PLEKHG1 PTPN13 PTPRK SYNE2 FGFR2 PITPNM2 FRAS1 CACHD1 OCLN | 2.39e-09 | 170 | 305 | 12 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK SYNE2 UNC13B PITPNM2 NEBL EPB41L5 SHANK2 | 2.39e-09 | 170 | 305 | 12 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | HTRA1 CRIM1 ITGA5 SCX HMCN2 MMP16 SOST SFRP4 PI16 ARHGDIG ARAP3 NRG3 | 3.55e-09 | 176 | 305 | 12 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 CRIM1 CAPN8 PLEKHG1 BMPR1B FGFR2 CNTN1 FRAS1 SORBS2 ERN2 SHANK2 OCLN | 5.18e-09 | 182 | 305 | 12 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | ERBB4 HMGCS1 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL CACHD1 SHANK2 ROS1 | 5.86e-09 | 184 | 305 | 12 | 369b82f793deab672204558ae4e112cfa5aa9ccc |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | ERBB4 CRIM1 CAPN8 PLEKHG1 PTPN13 PTPRK UNC13B PITPNM2 EPB41L5 CACHD1 SHANK2 OCLN | 6.23e-09 | 185 | 305 | 12 | 673f0c688ae6984bc8027df2da335787924f4137 |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 UNC13B NEBL EPB41L5 SHANK2 ROS1 OCLN | 6.62e-09 | 186 | 305 | 12 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPEG ITGA7 ARHGEF17 IFT43 ITIH4 BMPR1B CARNS1 CAP2 SOST VTN SLC4A8 CSPG4 | 7.03e-09 | 187 | 305 | 12 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPEG ITGA7 ARHGEF17 IFT43 ITIH4 BMPR1B CARNS1 CAP2 SOST VTN SLC4A8 CSPG4 | 7.03e-09 | 187 | 305 | 12 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | WSB1 ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 SHANK2 ROS1 | 7.47e-09 | 188 | 305 | 12 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 NEBL EPB41L5 ERN2 SHANK2 ROS1 | 7.93e-09 | 189 | 305 | 12 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 CACHD1 SHANK2 OCLN | 8.92e-09 | 191 | 305 | 12 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | ERBB3 ERBB4 PTPN13 PTPRK FGFR2 UNC13B NEBL EPB41L5 CACHD1 SHANK2 CELSR2 OCLN | 8.92e-09 | 191 | 305 | 12 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 NEBL EPB41L5 CACHD1 SHANK2 OCLN | 9.46e-09 | 192 | 305 | 12 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 MYOZ1 CACNA1H CAP2 PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.00e-08 | 193 | 305 | 12 | 5182284dfa7c94027e94172e08f78c86b95d63f4 |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | CRIM1 SPEG ITGA7 MYOZ1 CACNA1H CAP2 PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.00e-08 | 193 | 305 | 12 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ERBB4 CRIM1 AXL SMOC2 ITGA7 MYOZ1 CACNA1H CAP2 SORBS2 NT5DC2 FRZB CSPG4 | 1.12e-08 | 195 | 305 | 12 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | AXL SPEG SMOC2 ITGA7 ARHGEF17 DENND2B ZEB2 COL3A1 ZEB1 SGIP1 FN1 CSPG4 | 1.19e-08 | 196 | 305 | 12 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | AXL SPEG SMOC2 ITGA7 ITIH4 MYOZ1 CAP2 SORBS2 FN1 UNC45B FRZB CDH13 | 1.26e-08 | 197 | 305 | 12 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | AXL SPEG SMOC2 ITGA7 ITIH4 MYOZ1 CAP2 SORBS2 FN1 UNC45B FRZB CDH13 | 1.26e-08 | 197 | 305 | 12 | 31bc9fd679d78550541d4158568e8dd09ff29e8e |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ITGA7 ARHGEF17 CACNA1H COL3A1 FLNC SORBS2 TRIM42 UNC45B FRZB CSPG4 CDH13 | 1.33e-08 | 198 | 305 | 12 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ERBB4 HMGCS1 CAPN8 PTPN13 PTPRK FGFR2 UNC13B NEBL CACHD1 SHANK2 MTRR ROS1 | 1.33e-08 | 198 | 305 | 12 | f948391296c261c473d339069a6d0f20ccd6f38f |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 CACHD1 SHANK2 OCLN | 1.41e-08 | 199 | 305 | 12 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | PDGFB MPDZ PCDH12 MAPRE2 UNC13B FOXN2 FRAS1 GTF2I ARAP3 FRZB ATP2A3 CDH13 | 1.41e-08 | 199 | 305 | 12 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFB ITGA5 ITGB4 PLEKHG1 SHE COL3A1 ZEB1 FN1 PI16 ARAP3 TNXB CDH13 | 1.41e-08 | 199 | 305 | 12 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CATSPERE CRIM1 ITGB4 ZEB2 PDIA2 CNTN1 FN1 NEBL PCARE RGS3 CATSPERB | 1.47e-08 | 160 | 305 | 11 | 0293b244c063a62819690bf22bbc2681f8d15252 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CATSPERE CRIM1 ITGB4 ZEB2 PDIA2 CNTN1 FN1 NEBL PCARE RGS3 CATSPERB | 1.47e-08 | 160 | 305 | 11 | 3eaae86fa08f7651021316f8e5811bf48055591e |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPEG GPR152 PCDH12 ASTN2 NPHS1 CACNA1A FAT4 SOST NEBL MMP23B L3MBTL1 | 2.59e-08 | 169 | 305 | 11 | 87116c33c5ca8cb1862e103e5607b1df4d264569 |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | WSB1 ERBB3 ERBB4 CRIM1 HMGCS1 CAPN8 BMPR1B TBC1D8 SHANK2 CATSPERB OCLN | 3.94e-08 | 176 | 305 | 11 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | SMOC2 ITGB4 BMPR1B PTPN13 FGFR2 ALDH3A1 MMP12 CNTN1 FRAS1 CACHD1 SHANK2 | 4.42e-08 | 178 | 305 | 11 | fba2e38c05cbf031e0c6d47b1602575fea734a57 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB3 ERBB4 PTPRK FGFR2 UNC13B FRAS1 NEBL EPB41L5 SHANK2 CELSR2 OCLN | 4.69e-08 | 179 | 305 | 11 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | SPEG ITGA5 SMOC2 ITGA7 MMP16 COL3A1 PRUNE2 SGIP1 FN1 FAT3 CDH13 | 4.96e-08 | 180 | 305 | 11 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HTRA1 AXL SPEG SMOC2 ITGA7 CACNA1H CAP2 COL3A1 SFRP4 PI16 TNXB | 6.21e-08 | 184 | 305 | 11 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPHB2 SMOC2 ARHGEF17 RTN1 ASTN2 COL3A1 MMP23B CACHD1 ARVCF FRZB TNXB | 6.56e-08 | 185 | 305 | 11 | f814ec9d4ade717a0109398e9768d0d66f09317b |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 UNC13B CACHD1 SHANK2 ROS1 | 6.56e-08 | 185 | 305 | 11 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPHB2 SMOC2 ARHGEF17 RTN1 ASTN2 COL3A1 MMP23B CACHD1 ARVCF FRZB TNXB | 6.56e-08 | 185 | 305 | 11 | 40e958511790e84321da5ccf735f9974c06a0263 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPHB2 SMOC2 ARHGEF17 RTN1 ASTN2 COL3A1 MMP23B CACHD1 ARVCF FRZB TNXB | 6.56e-08 | 185 | 305 | 11 | 5f2eeba80aff145e85cfd81e2890a155406badb9 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB4 PFKFB2 CAPN8 PTPN13 FGFR2 UNC13B NEBL SHANK2 MTRR ROS1 OCLN | 7.32e-08 | 187 | 305 | 11 | 5df9e1f5ca32217af255e76e6fb5afa346337811 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HMGCS1 ANKRD36C BIRC6 ZEB2 SYNE2 TAOK1 MAPRE2 EML4 LNPEP SPEN TP53BP2 | 7.73e-08 | 188 | 305 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | SPEG ITGA7 MYOZ1 CACNA1H CARNS1 CAP2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 7.73e-08 | 188 | 305 | 11 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 ERBB4 CAPN8 ASTN2 FRAS1 DZIP1 LNPEP RIMBP2 NRG3 OCLN FYB1 | 8.16e-08 | 189 | 305 | 11 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFB ITGA5 ITGB4 PLEKHG1 SHE ZEB1 FN1 PI16 ARAP3 ATP2A3 CDH13 | 8.16e-08 | 189 | 305 | 11 | 12b6f1c3bf526b90e112374bf937701f645c5780 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ERBB3 ERBB4 SMOC2 PLEKHG1 MYO3B FGFR2 UNC13B FRAS1 SHANK2 RIMBP2 OCLN | 8.16e-08 | 189 | 305 | 11 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 ERBB4 CAPN8 ASTN2 FRAS1 DZIP1 LNPEP RIMBP2 NRG3 OCLN FYB1 | 8.16e-08 | 189 | 305 | 11 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | WSB1 ERBB4 GATA3 BMPR1B PTPN13 MYO3B FGFR2 IQUB FRAS1 NEBL RIMBP2 | 8.61e-08 | 190 | 305 | 11 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | CRIM1 ITGA5 PDE10A LYST ITGB4 PLEKHG1 SHE FAT4 ZEB1 CACHD1 NRG3 | 8.61e-08 | 190 | 305 | 11 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 NEBL SHANK2 ROS1 OCLN | 9.08e-08 | 191 | 305 | 11 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL CACHD1 SHANK2 ROS1 | 9.08e-08 | 191 | 305 | 11 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | ERBB3 ERBB4 CAPN8 BMPR1B PTPN13 PTPRK FGFR2 NEBL ERN2 SHANK2 ROS1 | 9.08e-08 | 191 | 305 | 11 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | SPEG ITGA7 ITIH4 MYOZ1 CACNA1H CARNS1 SORBS2 FRZB CSPG4 ATP2A3 CDH13 | 9.08e-08 | 191 | 305 | 11 | 2da83c493e60ad0278848957645277d76737a188 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | AXL SMOC2 ITGA7 ARHGEF17 DENND2B ZEB2 COL3A1 ZEB1 SGIP1 FN1 CSPG4 | 9.08e-08 | 191 | 305 | 11 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | AXL SMOC2 ITGA7 ARHGEF17 DENND2B ZEB2 COL3A1 ZEB1 SGIP1 FN1 CSPG4 | 9.08e-08 | 191 | 305 | 11 | cd854b9c426924fdc84bf7f411f6dea447143e79 |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 SMOC2 CAPN8 PLEKHG1 BMPR1B PTPN13 FRAS1 SORBS2 ERN2 SHANK2 OCLN | 9.08e-08 | 191 | 305 | 11 | 23776c7302cead3881b39127398f3b3e0d27885e |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | HTRA1 AXL SPEG ITGA7 ITIH4 CAP2 COL3A1 SOST MMP23B CSPG4 CDH13 | 9.58e-08 | 192 | 305 | 11 | a476895b7b252c388d6346eacbc72f0115b1443e |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B NEBL CACHD1 SHANK2 MTRR ROS1 | 9.58e-08 | 192 | 305 | 11 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.58e-08 | 192 | 305 | 11 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | ERBB3 ERBB4 ITGB4 CAPN8 BMPR1B PTPN13 FGFR2 ALDH3A1 CACHD1 ERN2 SHANK2 | 9.58e-08 | 192 | 305 | 11 | 59261098ccb52306f837f632ebaea45b90ad30fe |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPEG ITGA7 ARHGEF17 ITIH4 CAP2 SORBS2 VTN SLC4A8 AATK ARVCF CSPG4 | 9.58e-08 | 192 | 305 | 11 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFB ITGA5 ITGB4 PLEKHG1 SHE ZEB1 FN1 PI16 ARAP3 ATP2A3 CDH13 | 1.01e-07 | 193 | 305 | 11 | 0b328f725f6feba263783eaca60c142e80df90f3 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | WSB1 ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B NEBL EPB41L5 SHANK2 ROS1 | 1.06e-07 | 194 | 305 | 11 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ERBB4 SPP1 PTPN13 CLCN5 MYO3B ASTN2 FGFR2 FRAS1 NEBL EPB41L5 SHANK2 | 1.06e-07 | 194 | 305 | 11 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | ERBB4 OBSCN ASTN2 MAPRE2 PRUNE2 FRAS1 SORBS2 NEBL RGS3 GSG1L CDH13 | 1.06e-07 | 194 | 305 | 11 | 89812fb164065041357bb37a3c2d87028ec3de4e |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB3 AXIN2 CAPN8 BMPR1B PTPN13 PER2 PTPRK FGFR2 ERN2 NT5DC2 TNKS1BP1 | 1.06e-07 | 194 | 305 | 11 | 2172d951896265243d14996eacce5aab5e14e26e |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | AXL SMOC2 COL3A1 ZEB1 SGIP1 SPATA6 FN1 PI16 CATSPERB IRS2 TNXB | 1.06e-07 | 194 | 305 | 11 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | AXL SPEG SMOC2 ITGA7 DENND2B ZEB2 COL3A1 SGIP1 FN1 CSPG4 CDH13 | 1.06e-07 | 194 | 305 | 11 | ebb038f94f49f5c655578d1b018676e10c6b7e3c |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPEG SMOC2 ITGA7 MYOZ1 CACNA1H COL3A1 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.12e-07 | 195 | 305 | 11 | b3660779f274ca97dd844cf83f62d85ba88cb182 |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | ERBB4 DENND2B PTPN13 PTPRK SYNE2 FGFR2 SORBS2 NEBL SHANK2 CATSPERB ROS1 | 1.12e-07 | 195 | 305 | 11 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFB ITGA5 ITGB4 PLEKHG1 SHE ZEB1 FN1 PI16 ARAP3 ATP2A3 CDH13 | 1.12e-07 | 195 | 305 | 11 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPEG SMOC2 ITGA7 MYOZ1 CACNA1H COL3A1 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.12e-07 | 195 | 305 | 11 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | ERBB4 DENND2B PTPN13 PTPRK SYNE2 FGFR2 SORBS2 NEBL SHANK2 CATSPERB ROS1 | 1.12e-07 | 195 | 305 | 11 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 SMOC2 CAPN8 PLEKHG1 BMPR1B PTPN13 SYNE2 FRAS1 EPB41L5 ERN2 SHANK2 | 1.12e-07 | 195 | 305 | 11 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ERBB4 CAPN8 PTPN13 PTPRK FGFR2 UNC13B SORBS2 NEBL EPB41L5 SHANK2 ROS1 | 1.12e-07 | 195 | 305 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 ERBB4 HTRA1 RTN1 NLGN3 RNF128 MMP16 CNTN1 CACNA1A ASCL1 CSPG4 | 1.18e-07 | 196 | 305 | 11 | f374cb3ec31c6eef2cef9e07547bfd1e380553af |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | SPEG SMOC2 ITGA7 ITIH4 MYOZ1 CACNA1H CAP2 SORBS2 FRZB CSPG4 CDH13 | 1.18e-07 | 196 | 305 | 11 | c390ef0adff35111989a30dff86b7c5db1a89873 |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | SPEG SMOC2 ITGA7 ITIH4 MYOZ1 CACNA1H CAP2 SORBS2 FRZB CSPG4 CDH13 | 1.18e-07 | 196 | 305 | 11 | 2f76f050083483f0880639e6c34ff349caac3503 |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | AXL SPEG ITGA7 MYOZ1 CACNA1H PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.18e-07 | 196 | 305 | 11 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | CRIM1 SPEG ITGA7 MYOZ1 CACNA1H PRUNE2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.18e-07 | 196 | 305 | 11 | 541b1fcf509e362f6f48720046cb5378aaf7c591 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 ERBB4 HTRA1 RTN1 NLGN3 RNF128 MMP16 CNTN1 CACNA1A ASCL1 CSPG4 | 1.18e-07 | 196 | 305 | 11 | 671c380b58d7f634b4fbec38c357d357ea4f3535 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 SPP1 PTPN13 MYO3B SYNE2 ASTN2 PRUNE2 FRAS1 NEBL SHANK2 NRG3 | 1.24e-07 | 197 | 305 | 11 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CRIM1 AXL SPEG ITGA7 MYOZ1 FLNC SORBS2 UNC45B NT5DC2 FRZB CSPG4 | 1.24e-07 | 197 | 305 | 11 | aafe279b14cdcb786bc45524bc3c26261128ee48 |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CRIM1 AXL SPEG ITGA7 MYOZ1 FLNC SORBS2 UNC45B NT5DC2 FRZB CSPG4 | 1.24e-07 | 197 | 305 | 11 | fb14da600f563273059a4683a5079af81aca0886 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | CRIM1 SPEG ITGA7 MYOZ1 CACNA1H CAP2 SORBS2 UNC45B FRZB CSPG4 CDH13 | 1.31e-07 | 198 | 305 | 11 | 89986c7756541df364df516329d10775ba0e78a4 |
| Computational | Placenta genes. | EPHB2 ERBB3 ATP6V0A1 CRIM1 PDGFB SPP1 GATA3 PER1 PFKFB2 ITGA5 ITGB4 DENND2B PTPRO ACOT2 COL3A1 FN1 SLC18A3 CSPG4 OCLN PCDH1 TNXB HCLS1 | 3.92e-05 | 463 | 197 | 22 | MODULE_38 |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | EPHB2 PDGFB IQSEC2 ARHGEF17 CACNA1H CNTN1 FRAS1 SFRP4 DSC2 ARHGAP35 SLC22A18AS ARVCF SMARCC2 IRS2 ATP2A3 PRODH | 9.60e-09 | 196 | 304 | 16 | 2783_UP |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | WSB1 PDGFB ZMYND8 HMGCS1 ITGB4 BMPR1B AK5 FGFR2 MAPRE2 COL3A1 FN1 APBA2 RELA ZNF76 DCAF11 | 7.08e-08 | 197 | 304 | 15 | 4459_DN |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | EPHB2 WSB1 ATP6V0A1 PFKFB2 ITGA7 GDF9 MYOZ1 PTPRO COL3A1 DSC2 L3MBTL1 TESMIN SMARCC2 CATSPERB IRS2 | 7.57e-08 | 198 | 304 | 15 | 2312_UP |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; HL60; HG-U133A | EPHB2 SPG7 MYO9B PAK4 HMGCS1 RRP12 CNTN1 FLNC OCRL ARHGAP35 AATK YLPM1 FYB1 ATP6V0A2 | 5.10e-07 | 199 | 304 | 14 | 2028_UP |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | ERCC2 PER1 CACNA1H CNTN1 CACNA1A SFRP4 TAF1C RELA LIMK1 ABCG1 SPEN FYB1 FBXO21 | 2.25e-06 | 194 | 304 | 13 | 6835_UP |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | ERCC2 ADAM7 PFKFB2 ARHGEF17 RYR1 GIPR PER2 PRUNE2 ZEB1 SFRP4 ERN2 SLC22A18AS ARVCF | 2.38e-06 | 195 | 304 | 13 | 2290_UP |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; PC3; HT_HG-U133A | WSB1 TSPOAP1 PER1 ITGB4 BMPR1B NFKB2 FGFR2 SPATA6 EPB41L5 DZIP1 SHANK2 ARVCF FRZB | 2.52e-06 | 196 | 304 | 13 | 4490_UP |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | EPHB2 WSB1 IQSEC2 ZMYND8 NFKB2 ASTN2 CACNA1H FGFR2 DSC2 NEBL EPB41L5 RELA YLPM1 | 2.52e-06 | 196 | 304 | 13 | 6471_DN |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; PC3; HT_HG-U133A | NFKB2 HEMK1 CACNA1A SFRP4 DZIP1 ARHGAP35 SH3D21 ARG2 ARHGDIG CELSR2 ZNF76 FYB1 FBXO21 | 2.52e-06 | 196 | 304 | 13 | 4580_DN |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | MYO9B SPEG GATA3 PCDH12 CLCN5 RRP12 SORBS2 FN1 NEBL TAF1C OCRL FRZB ATP2A3 | 2.99e-06 | 199 | 304 | 13 | 5048_UP |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | EPHB2 TSPOAP1 ZMYND8 MPDZ ASTN2 MAPRE2 TAF1C EPB41L5 ARHGAP35 IDUA ERN2 SRRT FYB1 | 2.99e-06 | 199 | 304 | 13 | 5959_UP |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | EPHB2 ATP6V1A USP19 SUOX FOXN2 KLC2 ERN2 ABCG1 L3MBTL1 BTBD7 ZNF76 DCAF11 PCDH1 | 2.99e-06 | 199 | 304 | 13 | 6675_DN |
| Drug | AC1NUZ8M | 3.95e-06 | 92 | 304 | 9 | CID000073211 | |
| Drug | Grgd Peptide | 6.14e-06 | 10 | 304 | 4 | CID000126679 | |
| Drug | magnesium | MAG POP7 ATP6V1A ERCC2 SPG7 PAK4 PFKFB2 PDE10A AK7 TUFM RYR1 ITPA KCND2 AK5 DLD FGFR2 ALDH3A1 MMP12 PLK1 MMP16 DNASE1L2 CAP2 KIF11 ALPG DXO FN1 RASA1 RPP30 MMP23B POLRMT ARHGAP35 ERN2 ARHGDIA RNPEP AIFM1 GYS1 CARD11 ATP2A3 | 7.61e-06 | 1325 | 304 | 38 | CID000000888 |
| Drug | 1zp8 | 8.72e-06 | 77 | 304 | 8 | CID004369521 | |
| Drug | N-methyl-DL-aspartic acid | EPHB2 ERBB3 ERBB4 PER1 PDE10A ADCYAP1 ITIH4 RYR1 PER2 KCND2 NFKB2 AKT1 CACNA1H CACNA1A APBA2 RELA ARHGAP35 SHANK2 RNPEP AIFM1 MTRR CARD11 NRG3 PRODH | 8.88e-06 | 655 | 304 | 24 | CID000004376 |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | PDGFB MYO9B PER1 MPDZ ITGB4 NEBL KLC2 EPB41L5 ABCG1 SHANK2 SMARCC2 PRODH | 9.59e-06 | 189 | 304 | 12 | 5208_DN |
| Drug | LY294002; Up 200; 10uM; PC3; HT_HG-U133A | ZMYND8 PDE10A LYST ITGB4 HEMK1 SH3D21 ABCG1 L3MBTL1 LNPEP IRS2 FBXO21 ATP2A3 | 1.07e-05 | 191 | 304 | 12 | 5970_UP |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | MYO9B PER1 HMGCS1 PFKFB2 ITGA5 NFKB2 CACNA1H CACNA1A TAF1C EPB41L5 ARHGAP35 KDM4A | 1.25e-05 | 194 | 304 | 12 | 954_UP |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ATP6V0A1 ZMYND8 PFKFB2 ARHGEF17 CACNA1A SFRP4 DSC2 ERN2 RBCK1 SRRT BTBD7 PRODH | 1.25e-05 | 194 | 304 | 12 | 3625_DN |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | GATA3 HEMK1 ALDH3A1 MAPRE2 CNTN1 DZIP1 ARHGAP35 LIMK1 ABCG1 AATK L3MBTL1 BTBD7 | 1.31e-05 | 195 | 304 | 12 | 3737_DN |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | EPHB2 IQSEC2 ZMYND8 HMGCS1 NFKB2 CACNA1H FN1 ERN2 AATK ZNF76 IRS2 PRODH | 1.31e-05 | 195 | 304 | 12 | 2895_UP |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | PCDH12 ARHGEF17 RYR1 SORBS2 ZEB1 DSC2 EML4 ARHGAP35 ERN2 LNPEP SENP6 PCDH1 | 1.38e-05 | 196 | 304 | 12 | 2056_UP |
| Drug | Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A | WSB1 PDGFB SPEG PER1 PDE10A ARHGEF17 ITGB4 NEBL SH3D21 SRRT ABCG1 PCDH1 | 1.46e-05 | 197 | 304 | 12 | 4635_UP |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | EPHB2 ERCC2 LYST CLCN5 PER2 MMP16 CNTN1 FN1 DSC2 ARHGAP35 ARVCF FBXO21 | 1.46e-05 | 197 | 304 | 12 | 3859_UP |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A | PDGFB ITGA5 ITGB4 NFKB2 RRP12 ASTN2 FGFR2 ARHGAP35 ARVCF BTBD7 SENP6 CEP170B | 1.46e-05 | 197 | 304 | 12 | 1495_DN |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | PDGFB MMP16 CNTN1 DSC2 NEBL TAF1C APBA2 ARHGDIG LIMK1 BTBD7 FBXO21 PRODH | 1.46e-05 | 197 | 304 | 12 | 6091_DN |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | EPHB2 WSB1 ERCC2 CRIM1 PDGFB NFKB2 DSC2 EPB41L5 SRRT GTF2I IRS2 ATP2A3 | 1.46e-05 | 197 | 304 | 12 | 3889_DN |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | PDGFB PCDH12 ARHGEF17 MMP16 FN1 ARHGAP35 RGS3 SRRT SLC22A18AS ARHGDIG LIMK1 FBXO21 | 1.53e-05 | 198 | 304 | 12 | 6096_DN |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | EPHB2 CLCN5 ASTN2 FGFR2 MMP16 FOXN2 ARHGAP35 ERN2 LIMK1 AATK YLPM1 FYB1 | 1.53e-05 | 198 | 304 | 12 | 4681_DN |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | WSB1 ATP6V0A1 ITGA7 RTN1 GIPR MMP16 ALPG COL3A1 SPATA6 DSC2 FRZB CSPG4 | 1.53e-05 | 198 | 304 | 12 | 3748_UP |
| Drug | SC-560; Down 200; 10uM; PC3; HT_HG-U133A | ERCC2 PDGFB MYO9B ZMYND8 GATA3 ERN2 SRRT SLC22A18AS AATK CELSR2 CSPG4 PCDH1 | 1.53e-05 | 198 | 304 | 12 | 6865_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | EPHB2 TSPOAP1 PFKFB2 PDE10A GDF9 MYOZ1 MAPRE2 NPHS1 CACNA1A APBA2 ARVCF SENP6 | 1.61e-05 | 199 | 304 | 12 | 3872_UP |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | MYO9B IQSEC2 LYST MYOZ1 PTPRO FGFR2 KLC2 ARHGAP35 SLC22A18AS SHANK2 BTBD7 PRODH | 1.61e-05 | 199 | 304 | 12 | 2655_UP |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | EPHB2 ERCC2 ITGA7 ARHGEF17 RYR1 MAPRE2 SFRP4 FN1 SH3D21 SRRT ZNF76 RIMBP2 | 1.69e-05 | 200 | 304 | 12 | 3935_UP |
| Drug | tetrahydrofurfuryl methacrylate | 2.31e-05 | 5 | 304 | 3 | CID000017151 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | ZMYND8 HMGCS1 FGFR2 CAP2 P4HA2 ARG2 SLC22A18AS BTBD7 SENP6 KDM4A IRS2 | 2.75e-05 | 177 | 304 | 11 | 1643_UP |
| Drug | inchinko-to | 2.81e-05 | 14 | 304 | 4 | ctd:C078038 | |
| Drug | HCEC | 3.21e-05 | 119 | 304 | 9 | CID000194176 | |
| Drug | Fish Oils | 3.31e-05 | 149 | 304 | 10 | ctd:D005395 | |
| Drug | NSC236997 | SPP1 PFKFB2 LYST ZEB2 USP19 PTPRO AKT1 ACOT2 MMP12 MMP16 ZEB1 FN1 MMP23B PAF1 LIMK1 TESMIN AIFM1 GYS1 IRS2 SLC2A12 | 4.23e-05 | 539 | 304 | 20 | CID000005300 |
| Drug | genistein | ERBB3 ERBB4 ERCC2 PDGFB ITGA5 ITGA7 ITGB4 ADCYAP1 RYR1 CLCN5 PTPRK NFKB2 AKT1 CACNA1H FGFR2 MMP12 MMP16 PHIP KIF11 CACNA1A SFRP4 FN1 RASA1 BEAN1 MMP23B RELA ARHGDIA GTF2I CLCA3P SLC12A4 TESMIN APPL1 | 4.29e-05 | 1117 | 304 | 32 | CID005280961 |
| Drug | dermatan sulfate | GALNS SPP1 LYST ARSI ITIH4 FGFR2 CNTN1 COL3A1 VTN FN1 IDUA TNXB | 4.33e-05 | 220 | 304 | 12 | CID000032756 |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | AXL PDE10A RYR1 NPHS1 APBA2 TEX13B ARHGAP35 AATK L3MBTL1 ASCL1 ATP2A3 | 4.55e-05 | 187 | 304 | 11 | 3037_UP |
| Drug | phenyl glucuronide | 4.58e-05 | 6 | 304 | 3 | CID000087235 | |
| Drug | oxypertine | 4.65e-05 | 49 | 304 | 6 | CID000004640 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | ERBB4 ADAM7 LYST ITGB4 RRP12 TAF1C EPB41L5 ARHGAP35 ERN2 ARVCF RIMBP2 | 5.01e-05 | 189 | 304 | 11 | 4672_UP |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | ZMYND8 FGFR2 MAPRE2 P4HA2 EPB41L5 MINPP1 ARHGAP35 ARG2 LNPEP SENP6 SMARCC2 | 5.01e-05 | 189 | 304 | 11 | 836_UP |
| Drug | polysialoganglioside | 5.23e-05 | 50 | 304 | 6 | CID006450319 | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A | WSB1 ERBB3 BAP1 ALDH3A1 MMP16 NEBL ARHGAP35 ARAP3 BTBD7 GATAD1 DCAF11 | 5.26e-05 | 190 | 304 | 11 | 7154_DN |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A | ERCC2 MYO9B CD300A PER1 HEMK1 FOXN2 FN1 GTF3C1 ARVCF ZNF335 IRS2 | 5.26e-05 | 190 | 304 | 11 | 1396_UP |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | WSB1 ATP6V0A1 SPEG ADAM7 ITGB4 RRP12 FGFR2 SLC22A18AS TESMIN BTBD7 ATP2A3 | 5.52e-05 | 191 | 304 | 11 | 7486_UP |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A | EPHB2 WSB1 ERCC2 PDGFB ZMYND8 HMGCS1 ITGB4 PDIA2 CACNA1H DSC2 ERN2 | 5.78e-05 | 192 | 304 | 11 | 2846_UP |
| Drug | Methamphetamine | ATP6V0A1 PDGFB SPEG ZMYND8 OBSCN PER1 PFKFB2 TUFM LIME1 PER2 AK5 DLD ASTN2 AKT1 CARNS1 USH2A COL3A1 PRUNE2 FLNC P4HA2 FN1 TAF1C TRMT1 SMPD4 RELA PPP6R1 TEX13B ARG2 SRRT ARHGDIA ARAP3 L3MBTL1 SRPK3 SLC2A12 PCDH1 CDH13 PRODH | 5.93e-05 | 1401 | 304 | 37 | ctd:D008694 |
| Drug | Chloroprene | FAM185A CRIM1 PDGFB SPP1 CD300A GATA3 PER1 GBP3 HMGCS1 PCDH12 LYST ITGB4 SCX ZEB2 AK7 PER2 PTPRK PTPRO ACOT2 ALDH3A1 RNF128 PHIP COL3A1 FAT4 XRN2 FN1 NEBL EML4 EPB41L5 SH3D21 ARG2 CARD11 SRPK3 FYB1 HCLS1 PRODH | 5.99e-05 | 1348 | 304 | 36 | ctd:D002737 |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | ATP6V1A LYST ITGB4 DENND2B HEMK1 MMP16 SRRT GTF2I GATAD1 IRS2 ATP2A3 | 6.06e-05 | 193 | 304 | 11 | 6587_UP |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | EPHB2 ARHGEF17 HEMK1 APBB1IP COL3A1 PRUNE2 ZEB1 SFRP4 ARHGAP35 TESMIN FBXO21 | 6.35e-05 | 194 | 304 | 11 | 2258_UP |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | EPHB2 PDGFB USP19 FGFR2 ZEB1 TAF1C ARHGAP35 LIMK1 L3MBTL1 YLPM1 PCDH1 | 6.35e-05 | 194 | 304 | 11 | 5755_DN |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | EPHB2 MYO9B PFKFB2 HEMK1 FGFR2 FOXN2 NEBL DZIP1 ARHGAP35 AATK PCDH1 | 6.35e-05 | 194 | 304 | 11 | 5952_DN |
| Drug | Su-M | 6.55e-05 | 52 | 304 | 6 | CID000446388 | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | EPHB2 PDGFB MYO9B SPEG ITGA5 MMP16 SFRP4 SLC4A8 DSC2 L3MBTL1 TESMIN | 6.65e-05 | 195 | 304 | 11 | 3392_DN |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | ATP6V0A1 CRIM1 PDGFB ITGA5 DENND2B NFKB2 NEBL ABCG1 SHANK2 ARVCF PRODH | 6.65e-05 | 195 | 304 | 11 | 596_UP |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | EPHB2 PDGFB PDE10A ARHGEF17 LYST COL3A1 PRUNE2 FN1 SH3D21 SLC22A18AS FYB1 | 6.65e-05 | 195 | 304 | 11 | 6052_UP |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | IQSEC2 MPDZ BMPR1B MAPRE2 SORBS2 ZEB1 FN1 TAF1C AATK CELSR2 IRS2 | 6.65e-05 | 195 | 304 | 11 | 4428_DN |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | ATP6V0A1 CLCN5 CACNA1A SH2D2A ERN2 RGS3 SLC22A18AS BTBD7 SENP6 MTRR CEP170B | 6.97e-05 | 196 | 304 | 11 | 1840_UP |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | IQSEC2 MAPRE2 CACNA1A FN1 DSC2 NEBL TAF1C KLC2 ARG2 AATK GTF2I | 6.97e-05 | 196 | 304 | 11 | 3739_DN |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | MYO9B ZMYND8 ARHGEF17 BMPR1B PER2 SORBS2 DSC2 NEBL DZIP1 SRRT ARVCF | 6.97e-05 | 196 | 304 | 11 | 4288_UP |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A | EPHB2 SPEG PER1 RYR1 HEMK1 COL3A1 ERN2 L3MBTL1 SLC12A4 ARVCF FBXO21 | 6.97e-05 | 196 | 304 | 11 | 6416_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | WSB1 IQSEC2 ZMYND8 MYOZ1 CACNA1H CACNA1A APBA2 ERN2 RGS3 ATP2A3 PRODH | 6.97e-05 | 196 | 304 | 11 | 2232_DN |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | ZMYND8 PFKFB2 PER2 NFKB2 CNTN1 FN1 SHANK2 L3MBTL1 ARVCF YLPM1 CEP170B | 6.97e-05 | 196 | 304 | 11 | 2447_UP |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | ERBB3 PER1 MPDZ ITGB4 DENND2B HEMK1 FGFR2 ALDH3A1 L3MBTL1 ASCL1 FYB1 | 6.97e-05 | 196 | 304 | 11 | 3042_UP |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A | PDE10A USP19 BMPR1B RRP12 DZIP1 ERN2 SH3D21 SRRT GTF2I SLC12A4 FRZB | 6.97e-05 | 196 | 304 | 11 | 4283_UP |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A | PDGFB GATA3 LYST USP19 RRP12 MAPRE2 ZEB1 SLC4A8 DSC2 SH2D2A ERN2 | 6.97e-05 | 196 | 304 | 11 | 3760_DN |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | EPHB2 PDGFB PDIA2 HEMK1 FLNC SFRP4 ARHGAP35 ERN2 GTF2I ARVCF LNPEP | 6.97e-05 | 196 | 304 | 11 | 7496_DN |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | SPEG LYST PER2 MMP16 MAPRE2 ZEB1 ARHGAP35 TESMIN ARVCF IRS2 ATP2A3 | 6.97e-05 | 196 | 304 | 11 | 3849_UP |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | EPHB2 CRIM1 PDGFB ARHGEF17 USP19 MMP16 APBA2 SRRT LIMK1 ARVCF ATP2A3 | 6.97e-05 | 196 | 304 | 11 | 5577_DN |
| Drug | Excitatory Amino Acid Agonists | 7.17e-05 | 33 | 304 | 5 | ctd:D018690 | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | WSB1 PFKFB2 DENND2B MMP16 NEBL ABCG1 GTF2I CELSR2 BTBD7 DCAF11 FBXO21 | 7.29e-05 | 197 | 304 | 11 | 6311_UP |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | PFKFB2 PCDH12 ARHGEF17 ITGB4 RYR1 MYOZ1 RRP12 HEMK1 PRUNE2 SPATA6 ARHGAP35 | 7.29e-05 | 197 | 304 | 11 | 5045_UP |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | EPHB2 PER1 ITGB4 ASTN2 FN1 IDUA LIMK1 YLPM1 ZNF76 PCDH1 CEP170B | 7.29e-05 | 197 | 304 | 11 | 4295_DN |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | ATP6V0A1 MYO9B PER2 RRP12 MMP16 PRUNE2 FN1 DSC2 AATK RIMBP2 ATP2A3 | 7.29e-05 | 197 | 304 | 11 | 3686_UP |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; PC3; HT_HG-U133A | EPHB2 AXL ASTN2 HEMK1 CACNA1A SPATA6 SH2D2A WDR91 SRRT ARVCF ZNF76 | 7.29e-05 | 197 | 304 | 11 | 4102_DN |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | PDGFB GATA3 PDE10A ITGB4 GIPR RRP12 ASTN2 COL3A1 DCAF11 FYB1 PCDH1 | 7.29e-05 | 197 | 304 | 11 | 4636_UP |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | ERCC2 MYO9B SPEG ADAM7 ITGA7 LYST PRUNE2 FN1 SRRT IRS2 HCLS1 | 7.29e-05 | 197 | 304 | 11 | 3617_UP |
| Drug | DAPH; Up 200; 10uM; MCF7; HG-U133A | ERCC2 LSG1 ZMYND8 NFKB2 ERN2 AATK L3MBTL1 ZNF335 SMARCC2 KDM4A ATP2A3 | 7.29e-05 | 197 | 304 | 11 | 624_UP |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | ATP6V0A1 PDGFB LYST FGFR2 MMP16 TAF1C APBA2 ERN2 ARVCF FBXO21 PCDH1 | 7.29e-05 | 197 | 304 | 11 | 6078_DN |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A | WSB1 ERBB4 AK5 HEMK1 MMP16 DSC2 TAF1C RGS3 ABCG1 L3MBTL1 CSPG4 | 7.29e-05 | 197 | 304 | 11 | 4598_UP |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | WSB1 IQSEC2 ZMYND8 HMGCS1 LYST RRP12 FGFR2 MAPRE2 CACNA1A SLC4A8 FN1 | 7.29e-05 | 197 | 304 | 11 | 7177_UP |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | EPHB2 PFKFB2 ARHGEF17 CLCN5 HEMK1 FGFR2 DSC2 ARHGAP35 ERN2 ARHGDIG ATP2A3 | 7.63e-05 | 198 | 304 | 11 | 3621_DN |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | EPHB2 WSB1 ADCYAP1 CLCN5 CACNA1A SFRP4 SPATA6 DSC2 L3MBTL1 ARVCF FRZB | 7.63e-05 | 198 | 304 | 11 | 4446_UP |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | PDE10A CLCN5 MYOZ1 MMP16 MAPRE2 DSC2 SH2D2A SH3D21 SRRT ARHGDIG PRODH | 7.63e-05 | 198 | 304 | 11 | 2326_UP |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | PER1 ARHGEF17 USP19 CACNA1H FOXN2 APBA2 SH3D21 ARHGDIG FRZB IRS2 PRODH | 7.63e-05 | 198 | 304 | 11 | 1519_UP |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A | WSB1 TSPOAP1 PER1 PCDH12 RYR1 MYOZ1 CACNA1A FLNC ARHGDIG L3MBTL1 TESMIN | 7.63e-05 | 198 | 304 | 11 | 3197_UP |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | MYT1L ERBB4 ITGB4 NME8 NFKB2 FGFR2 USH2A PRUNE2 SPATA6 ARHGDIG L3MBTL1 | 7.63e-05 | 198 | 304 | 11 | 4101_UP |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | WSB1 GIPR MYOZ1 PRUNE2 SFRP4 ARHGDIG ASCL1 BTBD7 FRZB ZNF76 ATP2A3 | 7.63e-05 | 198 | 304 | 11 | 3750_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | WSB1 PER2 NFKB2 FGFR2 DNASE1L2 ZEB1 DSC2 APBA2 EPB41L5 ARHGAP35 SRRT | 7.63e-05 | 198 | 304 | 11 | 4348_DN |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | EPHB2 ATP6V0A1 MPDZ BMPR1B ASTN2 FGFR2 MMP16 MAPRE2 ZEB1 EML4 ARHGAP35 | 7.63e-05 | 198 | 304 | 11 | 4432_DN |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | EPHB2 MYO9B PER1 ITGA5 LYST CLCN5 MMP16 MAPRE2 CNTN1 SRRT SLC22A18AS | 7.63e-05 | 198 | 304 | 11 | 2251_DN |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | MPDZ ARHGEF17 MMP16 APBA2 SH3D21 SHANK2 TESMIN ARVCF BTBD7 ZNF76 IRS2 | 7.63e-05 | 198 | 304 | 11 | 2791_UP |
| Disease | Malignant neoplasm of breast | ERBB3 ERBB4 CATSPERE SPP1 OBSCN GATA3 PER1 ZEB2 NME8 BAP1 PER2 OTOF SYNE2 ASTN2 AKT1 FGFR2 ZEB1 FN1 NOA1 SMC6 RELA ARHGDIA ARAP3 UNC45B APPL1 OCLN SPEN ATP2A3 PCDH8 TP53BP2 PRODH | 1.55e-07 | 1074 | 296 | 31 | C0006142 |
| Disease | coronary artery disease | ERBB4 HTRA1 MYO9B DENND2B ZEB2 ITIH4 GIPR PLEKHG1 BMPR1B PTPRO ASTN2 MAPRE2 DXO P4HA2 FAT4 DNAJC13 SORBS2 ZEB1 FN1 TENT4A DOCK8 NOA1 CELSR2 ARVCF LNPEP ZNF335 FBXO21 SLC2A12 TNXB CDH13 | 4.22e-06 | 1194 | 296 | 30 | EFO_0001645 |
| Disease | urinary bladder cancer (is_marker_for) | 1.29e-05 | 107 | 296 | 8 | DOID:11054 (is_marker_for) | |
| Disease | Non-Small Cell Lung Carcinoma | 3.00e-05 | 156 | 296 | 9 | C0007131 | |
| Disease | Spastic Paraplegia | 8.03e-05 | 9 | 296 | 3 | C0037772 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.44e-05 | 139 | 296 | 8 | DOID:3908 (is_implicated_in) | |
| Disease | Gastric Adenocarcinoma | 8.64e-05 | 45 | 296 | 5 | C0278701 | |
| Disease | Colorectal Carcinoma | ERCC2 GALNS OBSCN PER1 ZEB2 AXIN2 AKT1 PHIP IQUB AGTPBP1 CNTN1 COL3A1 UNC13B FLNC SFRP4 FN1 ABCG1 ARAP3 MTRR | 9.96e-05 | 702 | 296 | 19 | C0009402 |
| Disease | Dent disease (is_implicated_in) | 1.00e-04 | 2 | 296 | 2 | DOID:0050699 (is_implicated_in) | |
| Disease | Dent disease | 1.00e-04 | 2 | 296 | 2 | cv:C0878681 | |
| Disease | FEV/FEC ratio | ERBB3 HTRA1 CRIM1 PDGFB SPEG ARHGEF17 DENND2B ZEB2 IFT43 SUOX SYNE2 ASTN2 FGFR2 FRAS1 NEBL SCAF8 EML4 EPB41L5 SH3D21 LIMK1 GTF2I ARVCF CSPG4 YLPM1 ATP2A3 TNXB ATP6V0A2 | 1.26e-04 | 1228 | 296 | 27 | EFO_0004713 |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.30e-04 | 49 | 296 | 5 | DOID:3910 (is_implicated_in) | |
| Disease | Congenital muscular dystrophy | 2.06e-04 | 12 | 296 | 3 | cv:C0699743 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.06e-04 | 12 | 296 | 3 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | alcohol and nicotine codependence | 2.65e-04 | 13 | 296 | 3 | EFO_0004776 | |
| Disease | X-24513 measurement | 2.99e-04 | 3 | 296 | 2 | EFO_0022133 | |
| Disease | Cutis Laxa, Autosomal Recessive, Type IIA | 2.99e-04 | 3 | 296 | 2 | C0268355 | |
| Disease | CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC | 2.99e-04 | 3 | 296 | 2 | C4479387 | |
| Disease | CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID | 2.99e-04 | 3 | 296 | 2 | C4479409 | |
| Disease | Malignant neoplasm of skin | 3.16e-04 | 59 | 296 | 5 | C0007114 | |
| Disease | Skin Neoplasms | 3.16e-04 | 59 | 296 | 5 | C0037286 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 3.35e-04 | 14 | 296 | 3 | EFO_0005257, EFO_1001482 | |
| Disease | Bipolar Disorder | ERBB3 ERBB4 PDE10A ADCYAP1 ITIH4 PER2 ASTN2 AKT1 FGFR2 CACNA1A SRRT SHANK2 NRG3 PRODH | 3.67e-04 | 477 | 296 | 14 | C0005586 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.29e-04 | 63 | 296 | 5 | DOID:0050866 (is_marker_for) | |
| Disease | Neoplasm Invasiveness | 5.69e-04 | 184 | 296 | 8 | C0027626 | |
| Disease | X-21658 measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0022121 | |
| Disease | arabitol measurement, xylitol measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0800148, EFO_0801067 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 5.94e-04 | 4 | 296 | 2 | C0410204 | |
| Disease | Cranioectodermal dysplasia | 5.94e-04 | 4 | 296 | 2 | cv:C4551571 | |
| Disease | kin of IRRE-like protein 2 measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0802678 | |
| Disease | Endometrial adenocarcinoma | 5.94e-04 | 4 | 296 | 2 | C1153706 | |
| Disease | receptor tyrosine-protein kinase erbb-3 measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0020701 | |
| Disease | glucose-6-phosphate measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0010485 | |
| Disease | longitudinal BMI measurement, non-small cell lung carcinoma | 5.94e-04 | 4 | 296 | 2 | EFO_0003060, EFO_0005937 | |
| Disease | tenascin-X measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0802121 | |
| Disease | tyrosine measurement, amino acid measurement | 5.94e-04 | 4 | 296 | 2 | EFO_0005058, EFO_0005134 | |
| Disease | Carcinoma in situ of stomach | 6.12e-04 | 17 | 296 | 3 | C0154060 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 6.12e-04 | 17 | 296 | 3 | DOID:2921 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 6.12e-04 | 17 | 296 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.12e-04 | 17 | 296 | 3 | C0496905 | |
| Disease | Schizophrenia | MYT1L MAG ERBB3 ERBB4 MYO9B ADCYAP1 HDAC3 ASTN2 AKT1 FGFR2 ALDH3A1 COL3A1 APBA2 RELA ARVCF VPS35 NRG3 TNXB PCDH8 PRODH | 6.61e-04 | 883 | 296 | 20 | C0036341 |
| Disease | Cutaneous Melanoma | 7.50e-04 | 41 | 296 | 4 | C0151779 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.50e-04 | 41 | 296 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.50e-04 | 41 | 296 | 4 | C0858252 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.31e-04 | 195 | 296 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 8.60e-04 | 19 | 296 | 3 | DOID:2876 (is_marker_for) | |
| Disease | Meningioma | 8.60e-04 | 19 | 296 | 3 | C0025286 | |
| Disease | Amphetamine-Related Disorders | 9.56e-04 | 75 | 296 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 9.56e-04 | 75 | 296 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 9.56e-04 | 75 | 296 | 5 | C0236804 | |
| Disease | melanoma | 9.57e-04 | 248 | 296 | 9 | C0025202 | |
| Disease | Malignant Head and Neck Neoplasm | 9.82e-04 | 44 | 296 | 4 | C0278996 | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 9.83e-04 | 5 | 296 | 2 | C0432235 | |
| Disease | bladder disease (biomarker_via_orthology) | 9.83e-04 | 5 | 296 | 2 | DOID:365 (biomarker_via_orthology) | |
| Disease | catechol sulfate measurement | 9.83e-04 | 5 | 296 | 2 | EFO_0021151 | |
| Disease | phenylalanine measurement, amino acid measurement | 9.83e-04 | 5 | 296 | 2 | EFO_0005001, EFO_0005134 | |
| Disease | 3-methyl-2-oxovalerate measurement | 9.83e-04 | 5 | 296 | 2 | EFO_0021021 | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 9.83e-04 | 5 | 296 | 2 | DOID:0110942 (implicated_via_orthology) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.07e-03 | 45 | 296 | 4 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Stomach Carcinoma | 1.16e-03 | 21 | 296 | 3 | C0699791 | |
| Disease | Breast Carcinoma | ERBB3 ERBB4 SPP1 GATA3 ZEB2 BAP1 AKT1 FGFR2 ZEB1 FN1 RELA ARHGDIA OCLN TP53BP2 | 1.18e-03 | 538 | 296 | 14 | C0678222 |
| Disease | Adenocarcinoma of lung (disorder) | 1.18e-03 | 206 | 296 | 8 | C0152013 | |
| Disease | Granulomatous Slack Skin | 1.34e-03 | 22 | 296 | 3 | C0376407 | |
| Disease | triacylglycerol 58:9 measurement | 1.34e-03 | 22 | 296 | 3 | EFO_0010443 | |
| Disease | Congenital muscular dystrophy (disorder) | 1.46e-03 | 6 | 296 | 2 | C0699743 | |
| Disease | Lung Neoplasms | 1.51e-03 | 265 | 296 | 9 | C0024121 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 1.53e-03 | 23 | 296 | 3 | C0079773 | |
| Disease | Malignant neoplasm of prostate | EPHB2 ERBB3 DCAF6 ERCC2 BAP1 BMPR1B PTPRK AKT1 DNASE1L2 ARG2 SENP6 SPEN PCDH8 ZMYM3 CDH13 | 1.53e-03 | 616 | 296 | 15 | C0376358 |
| Disease | Malignant neoplasm of lung | 1.55e-03 | 266 | 296 | 9 | C0242379 | |
| Disease | response to fenofibrate | 1.59e-03 | 50 | 296 | 4 | GO_1901557 | |
| Disease | neutrophil count | PDGFB RPN1 TSPOAP1 LSG1 GDAP2 IQSEC2 DENND2B SAMD15 RRP12 AKT1 MAPRE2 PRUNE2 CACNA1A DNAJC13 SGIP1 DOCK8 TARS2 MRPL4 TBC1D8 AATK GTF3C1 ARVCF LNPEP TNXB PRODH ATP6V0A2 | 1.67e-03 | 1382 | 296 | 26 | EFO_0004833 |
| Disease | stomach carcinoma (is_marker_for) | 1.73e-03 | 24 | 296 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Ureteral obstruction | 1.73e-03 | 24 | 296 | 3 | C0041956 | |
| Disease | Intellectual Disability | MYT1L PCDH12 BRWD3 TAOK1 FGFR2 PHIP DOCK8 TRMT1 SHANK2 ASCL1 ZNF335 SMARCC2 | 2.01e-03 | 447 | 296 | 12 | C3714756 |
| Disease | Epilepsy, Absence, Atypical | 2.04e-03 | 7 | 296 | 2 | C0751124 | |
| Disease | vanillylmandelate (VMA) measurement | 2.04e-03 | 7 | 296 | 2 | EFO_0800119 | |
| Disease | Juvenile Absence Epilepsy | 2.04e-03 | 7 | 296 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 2.04e-03 | 7 | 296 | 2 | C4281785 | |
| Disease | Akinetic Petit Mal | 2.04e-03 | 7 | 296 | 2 | C0001890 | |
| Disease | Absence Seizure Disorder | 2.04e-03 | 7 | 296 | 2 | C4553705 | |
| Disease | arabinose measurement | 2.04e-03 | 7 | 296 | 2 | EFO_0021030 | |
| Disease | laurylcarnitine measurement | 2.04e-03 | 7 | 296 | 2 | EFO_0021041 | |
| Disease | Epilepsy, Minor | 2.04e-03 | 7 | 296 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 2.04e-03 | 7 | 296 | 2 | C0014553 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.04e-03 | 7 | 296 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | myeloperoxidase measurement | 2.19e-03 | 26 | 296 | 3 | EFO_0005243 | |
| Disease | brain cancer (implicated_via_orthology) | 2.19e-03 | 26 | 296 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.43e-03 | 181 | 296 | 7 | DOID:684 (is_implicated_in) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.45e-03 | 27 | 296 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Williams Syndrome | 2.70e-03 | 8 | 296 | 2 | C0175702 | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 2.70e-03 | 8 | 296 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | Ependymoma | 2.70e-03 | 8 | 296 | 2 | C0014474 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 2.70e-03 | 8 | 296 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | creatinine measurement | SPEG OBSCN PFKFB2 BIRC6 BRWD3 RYR1 GIPR ASTN2 RNF128 NPHS1 P4HA2 DNAJC13 SCAF8 EPB41L5 ARG2 TBC1D8 CELSR2 CSPG4 CDH13 PRODH | 2.71e-03 | 995 | 296 | 20 | EFO_0004518 |
| Disease | Hyalinosis, Segmental Glomerular | 2.72e-03 | 28 | 296 | 3 | C0086432 | |
| Disease | heart failure | 2.74e-03 | 185 | 296 | 7 | EFO_0003144 | |
| Disease | Adenocarcinoma of large intestine | 2.85e-03 | 96 | 296 | 5 | C1319315 | |
| Disease | Profound Mental Retardation | 2.86e-03 | 139 | 296 | 6 | C0020796 | |
| Disease | Mental deficiency | 2.86e-03 | 139 | 296 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 2.86e-03 | 139 | 296 | 6 | C0025363 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSPEDAQDLPYLVTE | 201 | Q6UXB8 | |
| GTPEYLAPEVLEDND | 311 | P31749 | |
| LAPEVLEDNDYGRAV | 316 | P31749 | |
| DDYSLERVPPEENQR | 2136 | O00555 | |
| PGGESYQDLVQRLEP | 361 | O60825 | |
| LSPPGLEEEDVNGYV | 1146 | P21860 | |
| APERSPRGELDEEGY | 1136 | Q15303 | |
| LGDSPLVDDPLEYQA | 556 | Q9Y2D5 | |
| ASIVYIGLRDVDPPE | 191 | P78540 | |
| PVYEEVGAFPELIQD | 1406 | Q8WWN8 | |
| RVKIEPGVDPDDTYN | 396 | Q9H4A4 | |
| PERFQAEPYGLEDDT | 251 | O00192 | |
| GELVYEAPETVAAEP | 4126 | Q9NR09 | |
| EIINEDGRVPLQSPY | 956 | Q9H7T0 | |
| PIVTGPDEEERYLFV | 81 | Q5SY80 | |
| LSVVDPDSAPGEIEY | 1856 | Q6UVK1 | |
| PDSAPGEIEYEVQRA | 1861 | Q6UVK1 | |
| DREEPEAAYRLIQGP | 1971 | Q6UVK1 | |
| NIEFRDLSYSVPEGP | 76 | P45844 | |
| LREVPLGVGDIPYND | 51 | P59827 | |
| GARVLIVSEDPELPY | 156 | O95831 | |
| YFGDEQQIRTEPILP | 716 | Q9H2U9 | |
| PYEREDLAGQRPDVV | 471 | Q5FYB1 | |
| DLYPVINGGVPETTE | 161 | P30838 | |
| EQGYREEPTFIDPEA | 256 | Q6UXU4 | |
| IEAASPRGSEAPVEY | 1651 | Q6V0I7 | |
| VAATGISQYEDDLPP | 116 | Q7Z5R6 | |
| APEPRVIDREGVYEI | 66 | Q96Q83 | |
| EPVTYTAIDPGLQDA | 1001 | Q5VU97 | |
| NLLEEALVPGEYEEP | 771 | A5YM72 | |
| VPVRPPQQYSDDEDD | 386 | Q92560 | |
| IYEREDSEPFRQPAD | 1316 | Q6RI45 | |
| GRVAVEYLDPSPEVQ | 201 | O43684 | |
| YADIVDVLNSPLEGP | 351 | P49753 | |
| LPSGSYEEDPQTILD | 426 | Q9Y2T1 | |
| SPPYDVQIVDDEGNV | 396 | Q6NUN0 | |
| LPGPGNEASRELESY | 451 | P48546 | |
| YVPEGLELAALRPES | 41 | Q99767 | |
| DRLEVVYSVPDNVPG | 141 | Q8N1D0 | |
| ALEIGDVVAGNPYEP | 511 | A6NHC0 | |
| YEVLTVRATDGDAPP | 306 | Q9HCU4 | |
| RYEALRGEQPPDLET | 2186 | Q9HCU4 | |
| DSDDDPVLIPGARYR | 656 | Q58WW2 | |
| ITVLDVNEGPVFYPD | 466 | P55290 | |
| PDPYGFIVQTAEIAE | 1311 | Q9Y4F5 | |
| SYPETEEEGEALPVR | 236 | P78524 | |
| IGLEQDETYIPPGES | 161 | O00238 | |
| DETYIPPGESLRDLI | 166 | O00238 | |
| LDNPNYTIPEEGDIL | 696 | Q9UPW5 | |
| PGVDQEPRNLFYVER | 176 | Q02487 | |
| IYEVDDPSLPNDEGI | 946 | Q13625 | |
| GARERYGPNELPSEE | 31 | Q93084 | |
| GVPIRETPILDDYDC | 281 | O75129 | |
| YARRPTPNDDTLDEG | 466 | Q01581 | |
| RLDYQEGPPGVEISC | 911 | Q14624 | |
| LDYLVVDTPPGTSDE | 126 | Q9Y5Y2 | |
| RPDIQYPDATDEDIT | 176 | P10451 | |
| GPEYEEEEVAIPLTA | 161 | P20936 | |
| PGVVDLPEENREAAY | 91 | O60216 | |
| EEERDGQYFEPVVPL | 1326 | Q99666 | |
| EEERDGQYFEPVVPL | 1326 | O14715 | |
| NENPEAELPLTAGEY | 671 | O95153 | |
| LRPVYQEDTIPEESG | 481 | P49796 | |
| PTLPSGIEAAYEIEA | 326 | P39900 | |
| QDVPSPPSDYVERVD | 306 | Q16625 | |
| EYQIVTDPGDVPAFL | 446 | Q8TD20 | |
| RYNGEPEHIERNDAP | 131 | Q14739 | |
| PAYEVDVQARDLGPN | 316 | Q9NPG4 | |
| QTYEGPDELPEGAQL | 346 | Q8N6L0 | |
| EAGEAYRSLSDPIPQ | 726 | Q96PE2 | |
| LYRPDAVAQPVTEDE | 381 | Q5JPF3 | |
| DYEDTEERPRPQFAA | 456 | Q6IWH7 | |
| VGPAYQQLEESRIPD | 506 | P56975 | |
| PNAELEIRYPEDLEF | 596 | O94952 | |
| QPEVYVAAPGESLEV | 46 | P21802 | |
| YLPADIGNAEGEPVV | 236 | Q9NXN4 | |
| QDPRGIYDQVAGDLD | 1211 | O60500 | |
| DSVKLPDGYVPQVDD | 201 | Q8WUE5 | |
| PARPEVYDSLQDAAL | 91 | Q6N063 | |
| EEAAYQVREPAGPDA | 3041 | Q86XX4 | |
| AVVNLDPANEGLPYE | 41 | Q9H9Y4 | |
| QLELPAVSPEDDGEY | 376 | P20916 | |
| ISDRDSPDELPVYVG | 131 | A8MVJ9 | |
| TYGINIITPREDEDP | 486 | Q9H089 | |
| AELIEEYEVFDPTRP | 116 | Q9Y6K8 | |
| LAPEIRSYEDPAALD | 251 | Q9Y5R4 | |
| RGEEPVSPGEDTYLL | 2396 | Q8NDA2 | |
| VPASYQPDEEERARL | 226 | Q9BYM8 | |
| AVLGQYTEEPLSQEP | 981 | P52732 | |
| YVENPDLDRGGLEPE | 601 | Q76MJ5 | |
| PGSESPNRAVEYLLE | 11 | Q5JU85 | |
| RDAPVGEEEAPAKYV | 611 | Q9UBK8 | |
| IEDLEVASDPLYVPD | 251 | Q9UKG1 | |
| DPLTYPDGDRVLVAV | 91 | Q8N0U4 | |
| NILIPQDGDYREFPI | 441 | P40123 | |
| TVIYEDNQRPSGVPD | 66 | P01721 | |
| PPRDSGGREDLVYNI | 346 | P29323 | |
| QDVDERAAPLLGYLP | 371 | O15534 | |
| RLVSAEGDPIPEELY | 16 | P01127 | |
| VDERAVPLLGYLPQD | 346 | O15055 | |
| PSPELRQEGVTEYED | 116 | Q9Y468 | |
| DYTIEIVAVDSGNPP | 471 | Q08174 | |
| GSNAELVYSLEPEPA | 536 | Q08174 | |
| RPYTVRVGDENDNAP | 481 | O95206 | |
| RTGEVLNIPDAYADP | 336 | Q9Y233 | |
| YNPPVDATPDTRELE | 91 | Q8TEB1 | |
| EEEPSEVPQLRQPYA | 1741 | Q14315 | |
| LGAPSRPIEDDQEVY | 581 | O15117 | |
| LGIPVNYQDVASIDP | 671 | Q8IYU2 | |
| RASYDDIDDLVIPAP | 56 | O75164 | |
| DDRPESPEYSGGNIV | 611 | Q9NZV8 | |
| APVLVVYDDSDRPSG | 61 | P80748 | |
| REVPLPAGIYNLDDL | 166 | P18074 | |
| SEPRAETVPEEANYE | 146 | Q92917 | |
| PRTELDDEDSYPQGG | 16 | Q8TDT2 | |
| PDEVEYEPRGSRLLV | 41 | Q9UIQ6 | |
| DLEADGQPLTPDEYL | 186 | Q9H0R5 | |
| DIREVYQPGSVLDFP | 116 | P36915 | |
| DAVDTYIPVPARDLE | 241 | P49411 | |
| PEEYTGPRDAEGIAE | 131 | Q13087 | |
| DQALSEPIRYAIPEE | 26 | Q9Y5G1 | |
| EPIRYAIPEELDRGS | 31 | Q9Y5G1 | |
| ESPEPEDTQDGLYRQ | 376 | Q9BZ72 | |
| NRDYIPVEGELLFQP | 1036 | P16144 | |
| DGYPDRYQPRDEEVQ | 86 | O77932 | |
| LRLAEEYGPSPGESE | 6 | Q8TE96 | |
| EERGPEENYSRPEAP | 396 | O15379 | |
| TRAYEPDSVLPLADG | 201 | Q9Y2H9 | |
| RFEIEYQGDPELQPI | 721 | Q9NXE4 | |
| EDPLLPGNDVGRSSY | 461 | Q5XG87 | |
| LEIYATRLGPDDPNV | 351 | Q9H0B6 | |
| EYIATQGPLPETRND | 1006 | Q16827 | |
| TEAELATPEGIYERP | 266 | O15460 | |
| PRDGGTYEVRAENPL | 176 | Q5VST9 | |
| PPETLLEAYIEARDE | 301 | Q9H158 | |
| PEYRQQSAVPLDGET | 436 | P10696 | |
| EPRGAVEAELDPVEY | 6 | O75817 | |
| IRPEEEAYGEDGNPL | 36 | P18509 | |
| GGAYEAELRVTAPPE | 686 | P08648 | |
| AELRVTAPPEAEYSG | 691 | P08648 | |
| LNYIAIDVREEPGLP | 1251 | Q9Y4H2 | |
| QDAGPLLVENPRDYS | 691 | Q9NZ94 | |
| TYRIDPNVLLDPADE | 91 | Q8N7H5 | |
| LGVYGEPSRETPNLD | 46 | P34059 | |
| YPLPEEVDVLFNIDG | 41 | P23771 | |
| VYGPENTQPILDDVS | 476 | Q7L622 | |
| ATRLPGLGEPEVEYE | 486 | Q9HCM4 | |
| YGGDIPIIPDLEEVQ | 96 | Q96FT9 | |
| GAYIIEVIPDTPAEA | 411 | Q92743 | |
| PENVQPRFLEDEGLY | 301 | Q9P2K1 | |
| AGYDLALVQEVRDPD | 51 | Q92874 | |
| LYPSVDEEDAVEIRP | 241 | Q8NF50 | |
| RDQFDPASYIIGPEE | 196 | Q8WUU5 | |
| PRAEEYEFLTPVEEA | 151 | P52565 | |
| EYEFVTPVEEAPRGA | 176 | Q99819 | |
| EGSYDPLSPEEQELL | 216 | P50553 | |
| LSEEGDEPQYLDLPS | 756 | P02751 | |
| DAQLEEQGASYILPP | 191 | Q8TDV2 | |
| VPPLDREVGEDKSYN | 46 | P51795 | |
| SIEVPIPRDGEYVVE | 961 | Q12860 | |
| PGARLSDIEEVPNYE | 4361 | Q8TDW7 | |
| SVLNYDPPQRDEFLG | 581 | Q53R41 | |
| VIRPPLNGDSLTEYE | 91 | Q9NZV1 | |
| PLRTYADQPIDADVT | 31 | P09622 | |
| RVGPLIPEQDYERLE | 141 | Q674R7 | |
| KQEEARREYPLSPDG | 1001 | Q9P203 | |
| GYLAEEQATPENPTI | 1591 | O75165 | |
| ADTPIYNDEADPLVG | 291 | P35475 | |
| SDRPEGAEYINPGER | 1516 | Q99698 | |
| EVPEPTFLENLLRYG | 11 | Q9NQG1 | |
| EYDPVEARQGQDAIP | 166 | Q15555 | |
| NPDLYPVRRIDGLTD | 206 | Q8NA54 | |
| IVSPLYDIEGDDVPS | 81 | P32314 | |
| DLPEYQGEPDEISIQ | 41 | Q9BY32 | |
| IVDIAPYDIGGPDQE | 1441 | P02461 | |
| PDQERSLSAYPVGEE | 291 | O60383 | |
| YEAGGEKEQDPRLIP | 246 | Q13683 | |
| PSDVDNYDDIRTELP | 241 | Q9HC35 | |
| EDPRNGPLEEDGERY | 661 | P13807 | |
| ESNPEFLYVEGLPEG | 601 | P78347 | |
| DVDATVLRELYPDSP | 131 | Q3B7T3 | |
| ELGADEEQRVPYPAL | 61 | O95180 | |
| DPVDVVPQDGRNDFY | 76 | Q9ULU4 | |
| AGLQDYAPEITAPEE | 651 | Q9P1V8 | |
| EGDRDYRFPPIETRE | 1011 | Q9UPN6 | |
| EARAAEPDPDYENLR | 1321 | P21817 | |
| LEPSDVPQDVYSGVA | 946 | O00411 | |
| EPPGNDSIVRRYKED | 566 | Q9BXL7 | |
| EQLAQFYGPEPALEV | 66 | P59044 | |
| SSLGRELPYDPVDTE | 46 | Q8NC60 | |
| YVPPLGNFDVETLDI | 836 | Q9BXW9 | |
| KVPLPEDVSREAGYD | 1461 | Q9HC10 | |
| ILPYDATRVPLGDEG | 2246 | Q12923 | |
| RVILQPVEDDPSSDY | 926 | Q15262 | |
| YDAGEGLAEEQPSPR | 51 | A6NGG8 | |
| AALQLVVDPGDPRSY | 306 | O96013 | |
| EEERDGQYFEPVVPL | 1311 | P0DJD0 | |
| EYPGIPELSALEDVA | 96 | Q9Y4I5 | |
| TRYDLAVPPDETVEG | 41 | Q504T8 | |
| AERPLEIRGPYDVAN | 191 | P78346 | |
| ESPVSVYLRDLPGDE | 116 | Q9BVN2 | |
| APYIDDLSEEQRRAP | 261 | Q16799 | |
| VAAQVNGEPYDLERP | 96 | Q9BW92 | |
| NGEPYDLERPLETDS | 101 | Q9BW92 | |
| PEIPVEYNVLLNDGS | 3801 | O75445 | |
| DVNIDDIGEDIVPYP | 286 | O15034 | |
| TGPYGEERPREVQET | 41 | Q9NXH9 | |
| DQIEDGIQTTYRPDP | 451 | Q8IWZ5 | |
| ERDVLLDEPPQGLYD | 481 | Q16572 | |
| RPEYGLEAAPEKDTV | 426 | Q2YD98 | |
| LDSYSPIPEGAVAEE | 466 | Q8WUY3 | |
| IYEPGREFVPSNAEL | 2146 | Q8WUY3 | |
| DSLELPTGDPQYLTE | 191 | Q9BYD3 | |
| YQPEAPDELALRRGD | 76 | A4FU49 | |
| PSNIYVEVEDEGLPA | 301 | Q9NP31 | |
| EAIIIPYRVDVGNPE | 3276 | Q8WXH0 | |
| LPSEELAYDSVPAGE | 1021 | Q6IEE7 | |
| QSPRTQPRDEDYEGA | 671 | Q8N5C8 | |
| LEQYDPPELADSSGR | 181 | Q96KG9 | |
| PRTLEGLQVEEEPVY | 346 | P14317 | |
| YLFDQESPTRELGEP | 1241 | Q6ZMQ8 | |
| EVAPEQPSDLRIGFY | 131 | O75900 | |
| DAYVPPEGDARISSL | 86 | Q9BRJ2 | |
| PEDGLRQIYRDPETL | 366 | Q15572 | |
| DPEPEQDYDEALGRL | 71 | Q8WZA1 | |
| LETYPAPRESLDDRG | 411 | A3QJZ6 | |
| GNVAEDDVGPIIYDP | 221 | Q9H479 | |
| RARAAEIGYEDPINP | 451 | O43272 | |
| SEEGVYGQDSPLEPV | 66 | Q8TEB7 | |
| IEIDSPYEISRAPDE | 381 | P04843 | |
| VPLLEVYPVEGQDTD | 231 | Q9BZQ2 | |
| PEEENYREEGDPRTR | 401 | Q7L7X3 | |
| SNEPDGVLSYQRPDE | 6 | Q2Y0W8 | |
| EVINYEDIEALIGPP | 736 | Q9UQ90 | |
| NDATEIIPELGEYPE | 31 | Q9BQB4 | |
| DNAVIPYETDEDPRR | 1201 | Q9NRY4 | |
| RLPIEDPYLEDSEAS | 641 | Q8TAQ2 | |
| QEDDDLIRAYASPGP | 686 | Q86YF9 | |
| RAEPFEGYLEPNETV | 616 | Q01968 | |
| IEYLLEEENQSGPPA | 551 | O94875 | |
| VVPVDGPRRGDYDNL | 6 | Q9UP95 | |
| AEEEELEIPPQYQAG | 1201 | Q5JTH9 | |
| LDEERLLREYPQPVG | 116 | Q9UPX8 | |
| AVEVLIGAEYGPPAD | 431 | Q9UPE1 | |
| GDPRAIVEYRDLDAP | 856 | Q9BXP5 | |
| EEVGAERAPEYTEPL | 91 | Q9HCU9 | |
| ERAPEYTEPLGGLQR | 96 | Q9HCU9 | |
| AQRPREEEPDSDYSV | 281 | Q9UGN4 | |
| YDGIVIAINPSVPED | 31 | Q9Y6N3 | |
| ISQASEYDDPPGLRE | 1836 | A5YKK6 | |
| ISDYADSVPDPEALR | 156 | Q9Y3A4 | |
| AGLDPDTDYDVALVP | 271 | Q6PCB0 | |
| NPDIAFPGERVYEVV | 706 | Q8IWX7 | |
| YEESPERDTPVDAQR | 371 | O94967 | |
| PYTETVDSDGRPDEV | 611 | O94966 | |
| DESYPALLTDIPVGD | 816 | Q7Z392 | |
| LGPRTVEEAIEYFPE | 401 | Q8N427 | |
| PTEEEGYPLLSAEIE | 511 | O75970 | |
| SYTGRDIPELPEREE | 1116 | O75970 | |
| RGLPPSIDAVYENSD | 386 | P51512 | |
| TRYEDVNPVLLSGPE | 51 | Q9UNW1 | |
| DRDLRTDYNEPGTIP | 71 | Q96T58 | |
| EDSEPFRQPVDLLEY | 1336 | Q8WWQ0 | |
| RPLINGGENEDEYEP | 251 | Q8NCC5 | |
| AEEEDGIYRPSPAGT | 2366 | Q15772 | |
| FYEPDPQETEARIVG | 3161 | Q15772 | |
| PENLACEELPVYDRG | 131 | Q92765 | |
| AEREEPPEQRGLAYG | 16 | Q9GZP4 | |
| LDEEGYSIRPEEPGS | 81 | Q9BQI5 | |
| QPQGDEEDIASRYPT | 181 | Q9H3U7 | |
| RESPESEGPIYEGLI | 781 | Q96QK1 | |
| YPLQEVVDDEVSGPS | 21 | A6NKU9 | |
| DELPVYDRGVCISPE | 126 | Q6FHJ7 | |
| DQEPYPVTDISDLIR | 751 | O95759 | |
| EGTPGLPLQQAEERY | 576 | Q9C0C2 | |
| ALEEVYPDLTPEETR | 661 | Q9H0D6 | |
| ENEVTVPGLDPDRKY | 1311 | P22105 | |
| EGLPYFLEEPEDRTV | 136 | P30530 | |
| GPNVPALLEAIDDAY | 481 | Q96SB8 | |
| VIDSNPGQEESDPRY | 836 | Q9GZR1 | |
| PPGNYDTSDVVLELE | 181 | P38606 | |
| YEEEVLENADLPTAP | 91 | P08922 | |
| EYVRDLPVLQGQVPE | 1046 | O14795 | |
| LGTAYRGLQPVPDEE | 141 | Q9H857 | |
| RGLQPVPDEEVIELY | 146 | Q9H857 | |
| AREGPDPYSVRVEDG | 156 | Q9UFB7 | |
| PTVPLAREYSVEAEE | 201 | Q8IUF8 | |
| LQLPDDYDTRASEPG | 2081 | P49750 | |
| VTQEPPDSGEERLRY | 61 | Q9UPN7 | |
| YTAEGAQEEPQVEPL | 721 | P37275 | |
| EIENPLEDPVTGDYV | 201 | Q93050 | |
| PNAIPGRTDIELEIY | 66 | O43670 | |
| LREGYNEPAADGPSE | 221 | Q6ZT12 | |
| VDDGYNVQPDTVAPI | 511 | P51687 | |
| AVEENIYDTIGLPDP | 736 | Q9ULL1 | |
| DEDYPVQVAPLSNGL | 341 | Q9Y6I7 | |
| DTAIIYPEAPEELSR | 171 | O60315 | |
| GISFYEEPRERPDLQ | 56 | Q12789 | |
| YPEVSPLSEDEDRGS | 16 | Q7RTU7 | |
| DSRLPENDERPAAEY | 311 | Q5VZ18 | |
| RNLDPEEPIQTSGYI | 621 | Q9P2L0 | |
| AEPAQASGPYVEIIE | 11 | Q04206 | |
| SDYNPAEDEPRGRQL | 321 | Q9H4Z2 | |
| RPEQPFIVLGQEEYG | 391 | A4D1P6 | |
| EDGVLDPDYPRNISD | 231 | P04004 | |
| PDAVDPGDVVTQLEY | 66 | Q9NWH7 | |
| DPLYINIERAEEPTA | 801 | Q06418 | |
| EITRPNGERYEPDSI | 1121 | Q14202 | |
| PREGYDPSTLEAVQL | 76 | P36508 | |
| ERYAEAGPAPAEVLQ | 201 | Q9BXU2 | |
| PYPNTAEERREIQEG | 251 | Q9Y487 | |
| NITPREGDELARLPY | 496 | P53350 | |
| NVRPEDPVDFLAEYL | 701 | Q96M32 | |
| RALDVDSGPLENVYE | 241 | Q9H400 | |
| EIIGRVNADPDYLPR | 541 | P53667 | |
| GIDAVPVEYEDNRPL | 766 | Q8WXR4 | |
| TYRLPELDPRGSDEE | 1981 | Q13459 | |
| PVDYNVDIGIPLDGE | 281 | Q9NP98 | |
| PFQEALEERRYPGEV | 846 | Q9UL68 | |
| RDGDYIVNVQPIDDG | 976 | O76041 | |
| APETADGPYLVIVEQ | 31 | Q00653 |